SALLY A. AMUNDSON
is an associate professor of radiation oncology in the Center for Radiological Research at the Columbia University Medical Center in New York. She holds a doctorate in radiation biology and cancer biology from the Harvard School of Public Health. Her research uses functional genomics approaches to study low dose radiation and bystander effects, unique effects of space radiation, and the development of gene expression approaches for radiation biodosimetry.
She is co-director of the Center for High-Throughput Minimally-Invasive Radiation Biodosimetry. Prior to joining the group at Columbia, Dr. Amundson worked on molecular radiation biology in the Division of Basic Science at the National Cancer Institute (NCI), where she helped to develop global gene expression profiling techniques, and where she was an adjunct investigator in the NCI Radiation Epidemiology Branch. She has served on the NCRP since 2004 and on the Science Advisory Committee of the Radiation Effects Research Foundation (RERF) in Hiroshima since 2009, chairing the RERF scientific review for 2012.
Dr. Amundson is an associate editor of Radiation Research, and has served on the organizing and program committees for numerous meetings, including two of the American Statistical Association Conferences on Radiation and Health, which aim to integrate radiation biology with epidemiology. She is a recipient of the Michael Fry Research Award from the Radiation Research Society (RRS), and she is also a member of the RRS Council.
Jeri L. Anderson
is the Radiological Assessment Team Lead at the Centers for Disease Control and Prevention (CDC) serving as subject matter expert in CDC’s radiation emergency preparedness and response activities. He received his BS and PhD degrees in radiation biophysics from the University of Kansas, starting his career as a radiation biologist, and did his postdoctoral research in radiation-induced mutagenesis at Oak Ridge and Los Alamos National Laboratories. He was a senior scientist with the radiological consulting firm of Auxier & Associates before joining CDC in 2002. He has led the development of key national guidance documents including guides for population monitoring and operation of public shelters after radiation emergencies and a number of training products for public health professionals. He is a past president of the Health Physics Society, adjunct associate professor of nuclear and radiological engineering at Georgia Institute of Technology, member of Georgia East Metro Medical Reserve Corps and Gwinnett County Community Emergency Response Team, and provides consultancy to the International Atomic Energy Agency. Since 2014, he has served as member of the U.S. delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation. He is the author of Radiation Threats and Your Safety: A Guide to Preparation and Response for Professionals and Community, a book specifically directed at audiences without radiation protection expertise.
A. IULIAN APOSTOAEI
is a researcher at SENES Oak Ridge, Inc., Center for Risk Analysis, Oak Ridge, Tennessee and an adjunct professor in Nuclear Engineering Department at the University of Tennessee, in Knoxville, Tennessee. He has more 20 y of experience in various aspects of radiological assessment. He served on the NCRP scientific committee in charge of the NCRP Report No. 164 on Uncertainties in Internal Radiation Dose Assessment. In support of epidemiologic studies performed by the National Institute of Occupational Safety and Health, Dr. Apostoaei has developed computational tools for estimation of doses from intakes of plutonium and uranium by analysis of bioassay data, using the most recent International Commission on Radiological Protection (ICRP) models.
Dr. Apostoaei was involved in the historical dose reconstruction project for members of the public at the Idaho National Engineering Laboratory, sponsored by the Centers of Disease Control and Prevention. He also contributed to the reconstruction of doses and estimation of risk of cancer for individuals exposed to historic releases of 131I from the Oak Ridge Reservation, as well as the estimation of radiation doses and risk of cancer from exposure to various radionuclides released to the Columbia River from Hanford Nuclear Facilities and to the Clinch River from the Oak Ridge National Laboratory. As part of these projects, Dr. Apostoaei determined the uncertainties in doses per unit intake from ingestion of 131I, 137Cs, 106Ru, and 60Co by using the most recent ICRP biokinetic and dosimetric models and developed risk coefficients for estimation of risk of thyroid and other cancers.
Dr. Apostoaei participated in the update of the Radioepidemiological Tables for the Radiation Epidemiology Branch of the National Cancer Institute, and is one of the main authors of the Interactive Radio-Epidemiological Program (IREP). IREP is currently used to estimate the probability of cancer causation for nuclear workers from exposure to radiation.
Dr. Apostoaei has been involved in various international projects for testing radiological assessment models using Chernobyl accident data, under the auspices of the International Atomic Energy Agency and has participated in validation exercises for dosimetry and environmental transport models applied to reconstruction of 137Cs doses to people from Czech Republic and Finland exposed in the aftermath of Chernobyl accident, and 131I dose to individuals exposed to releases from the Hanford Nuclear Facility.
Kimberly E. Applegate
is a professor of radiology and pediatrics and director of practice quality improvement in radiology at Emory University in Atlanta. At Emory University, she chairs the Radiation Control Council which reviews policy, clinical and research activities involving the use of ionizing radiation. Kimberly is dedicated to service in organized radiology—she is the President of the Association for University Radiologists (AUR) Research and Education Foundation, Past President of AUR, and served on multiple medical boards and editorial boards. Dr. Applegate has published over 140 peer-reviewed papers and book chapters, and presented scientific papers and lectures at medical and scientific assemblies around the world. In 2007, Dr. Applegate was elected to both the NCRP and the Steering Committee of the American College of Radiology (ACR), and began work on the initial Steering Committee for the Image Gently® Campaign to reduce radiation exposure in children. The Campaign has received a number of awards and collaborates internationally to change imaging practice. She is the national and international outreach chair for this campaign. In 2010, she co-edited the book “Evidence-Based Imaging in Pediatrics” to promote appropriate use of medical imaging in infants and children. Most recently, she co-authored the ICRP Publication 121, Radiological Protection of Paediatric Diagnostic and Interventional Radiology. She has long had an interest in the development of imaging guidelines, chairing this process for ACR, and collaborating with the World Health Organization and the International Atomic Energy Agency on international guideline development. Dr. Applegate is the ACR Vice Speaker and member of its Executive Committee.
EDOUARD I. AZZAM
Edouard I. Azzam is Professor in the Department of Radiology at Rutgers University - New Jersey Medical School. He received his doctoral degree in the field of radiation biology from the University of Ottawa (Canada) in 1995. From 1995 to 2000, he pursued post-doctoral studies at the Harvard School of Public Health under the mentorship of Professor John B. Little.
His research program has focused on elucidating the mechanisms underlying the biological effects of low doses/low fluences of ionizing radiations that differ in their biophysical characteristics. The goal is to elucidate the role of intercellular communication and oxidative metabolism in radiation-induced nontargeted effects and adaptive responses. The outcome of these investigations may be significant towards reducing the uncertainty associated with current models for predicting the long-term health risks of exposure to radiation. His studies have been funded by the National Institutes of Health, the National Aeronautics and Space Administration, and the U.S. Department of Energy; and they have resulted in the training of numerous students and post-doctoral fellows who remain engaged in unraveling the biochemical events underlying the responses of human cells to ionizing radiation.
is a Clinical Professor of Radiology and Medicine at Columbia University. He earned an MS in Radiological Physics and a PhD in Experimental Physics. He is certified in Radiological Physics by the American Board of Radiology and licensed by New York State in Diagnostic Imaging, Radiation Therapy Physics, and Medical Health Physics. He is a past President of the Radiological and Medical Physics Society of New York, past Vice President of the Radiological Society of North America, a member of the Standards and Safety Committees of the Society for Interventional Radiology, and a member of editorial and review boards of several scientific journals. He received the Marvin M.D. Williams award from the American Association of Physicists in Medicine (AAPM) in 2017. He is a fellow of AAPM, the American College of Medical Physics, the American College of Radiology, the Society for Cardiovascular Angiography and Interventions, and the Society of Interventional Radiology. He currently serves on International Electrotechnical Commission working groups responsible for safety and performance standards for projection and interventional radiology. He has been a member of NCRP Council for more than a decade. He chaired scientific committees that produced NCRP Report No. 168, Radiation Dose Management for Fluoroscopically-Guided Interventional Medical Procedures and NCRP Statement No. 11, Outline of Administrative Policies for Quality Assurance and Peer Review of Tissue Reactions Associated with Fluoroscopically-Guided Interventions (2014). He has over 100 refereed publications in the areas of radiological imaging, radiological health, and related topics.
DANIEL J. BARNETT
is an Associate Professor in the Department of Environmental Health Sciences at the Johns Hopkins Bloomberg School of Public Health. He has a Joint Faculty appointment in the Department of Health Policy and Management at the school. He is affiliated with the Centers for Disease Control and Prevention funded Johns Hopkins Center for Public Health Preparedness.
His research interests include best practice models to enhance all-hazards public health emergency preparedness and response, with a strong interest in preparedness for radiological and nuclear terrorism threats. Specific areas of focus include willingness of health providers to respond to public health emergencies, risk communication; personal and family emergency preparedness planning, vulnerable populations in emergencies, and psychosocial impacts of disasters. He received a BA in English from Yale University, and his MD degree at the Ohio State University College of Medicine and Public Health; his MPH degree was earned at the Johns Hopkins Bloomberg School of Public Health and he is a graduate of the Johns Hopkins General Preventive Medicine Residency Program.
Jonine L. Bernstein
is an Attending Epidemiologist at the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. Her core research focus is on breast cancer and gliomas and on understanding cancer risk and progression in order to identify those at highest risk because of gene carrier status, environmental exposures, or a combination of both. Dr. Bernstein is the Principle Investigator of the National Cancer Institute (NCI)-funded international 24-center Women's Environmental Cancer Radiation and Epidemiologic (WECARE) Study which was specifically designed to examine the interaction of radiation exposure and genetic predisposition in breast cancer, especially radiation-associated contralateral breast cancer (CBC) among 3,700 women with CBC and unilateral breast cancer. The WECARE Study has served as the source population for studies of candidate genes such as BRCA1, BRCA2, CHEK2, and ATM, candidate gene pathways of DNA damage response involved in radiation-induced double-strand break repair—ATM, CHEK2, P53 binding protein (53BPI), and MDC1, Mre11, Rad50, and Nbs1 (e.g., MRN nuclease complex), a genome-wide association study, and most recently mammographic density. The global hypothesis across these studies is that women who carry certain types of mutations will be more susceptible to breast cancer than noncarriers, and possibly to radiation-associated breast cancer.
Dr. Bernstein currently serves as a member of the Board of Directors of the American College of Epidemiology, the External Advisory group for the NCI-sponsored Breast Cancer Family Registry, the National Council on Radiation Protection and Measurements, and most recently the NCI Board of Scientific Counselors-Clinical Sciences and Epidemiology. For the past two years, she has served on the Organizing Committee of the American Statistical Association Conference on Radiation and Health (2012 and 2014 meetings), and was Co-Chair of the Third North American Congress of Epidemiology, held in June 2011 for which she was honored by the 2012 ACE Award for Leadership and Service in Epidemiology. Dr. Bernstein holds a PhD in Epidemiology from Yale University, an MS in Applied Biometry from the University of Southern California, and an AB from Brown University. Before joining the faculty at MSKCC, she was Deputy Director of the Division of Epidemiology at Mount Sinai School of Medicine.
earned his BSc degree in physics in 1977 from the University of São Paulo, Brazil; his MSc degree in nuclear engineering in 1980 from the Military Institute of Engineering, Rio de Janeiro; and PhD degree in biophysics in 1990 from the Federal University of Rio de Janeiro. He worked as a postdoctoral fellow at the University of Utah, Environmental Radiation Toxicology Laboratory from 1991 to1995. He has worked for more than 30 y in mathematical modeling of human metabolism regarding intake, distribution, retention and excretion of radionuclides for several age groups for internal dosimetry applications; scientific software design and development including software quality assurance procedures; and interpretation of monitoring data of radiation workers.
He is currently an Internal Dosimetrist at Los Alamos National Laboratory since 2003. He was responsible for calculating all internal doses and evaluating the efficacy of Prussian Blue for all age groups due to the Goiania radioactive accident in 1987. He has been serving the International Commission on Radiological Protection as a member of the Task Group on Dose Calculations since 1995 and as a member of Committee 2 since 2013. He has published several peer-reviewed journal articles.
WILLIAM F. BLAKELY
is a Senior Staff Scientist in the Radiation Biodosimetry Research Program at the Armed Forces Radiobiology Research Institute (AFRRI), Uniformed Services University of the Health Sciences (USUHS). He received his BA in Zoology in 1974 at San Diego State University and PhD in Radiation Biology in 1980 at the University of Illinois-Urbana-Champaign under the supervision of his doctoral advisor, Dr. Howard S. Ducoff. He completed his postdoctorate study on DNA radiation chemistry in Dr. John F. Ward's laboratory at the University of California, San Diego. In 1983 he joined AFRRI/USUHS, his present affiliation. Dr. Blakely's research activities have focused on molecular mechanisms of radiation sensitivity, cell-cycle effects, DNA damage and repair, and biological dosimetry. He served as a guest editor for several issues of journals associated with international meetings, an associate editor for the Radiation Research, and Chairman of the NATO Research Study Group-Radiation Bioeffects and Countermeasures. He presently is the course director of the Radiation Biology graduate course at his University.
He also serves as a U.S. representative on the ISO TC85/SC2 (Radiation Protection) Working Group 18 (Performance Criteria for Service Laboratories Performing Biological Dosimetry by Cytogenetics), an assistant professor in the Uniformed Services University of the Health Sciences Preventive Medicine and Biometrics Department, and an senior associate faculty at Radiation Emergency Assistance Center/Training Site. Elected as a Council member in 2003 and is currently serving a second 6 y term. He served as the Program Chair of NCRP 2004 Annual Meeting entitled: Advances in Consequence Management for Radiological Terrorism Events and is currently a member of NCRP PAC 6 - Dosimetry.
DANIEL J. BLUMENTHAL
manages the Consequence Management programs in the Office of Emergency Response at the National Nuclear Security Administration within the U.S. Department of Energy (DOE). The programs include atmospheric dispersion modeling, air and ground-based radiation monitoring, and radiation medicine. In 2009, he transferred from the U.S. Department of Homeland Security's Domestic Nuclear Detection Office where he was the Chief Test Scientist. He was responsible for designing and conducting field test campaigns for radiation detection systems as applied to the preventive radiological/nuclear detection mission as well as providing subject matter expertise on detector applications and performance. Prior to joining the Federal government he was a Senior Scientist at DOE's Remote Sensing Laboratory from 1996 to 2006 where he managed or provided scientific support to several DOE emergency response teams. Most recently Dr. Blumenthal led the initial DOE response team to Japan where he spent a total of seven weeks following the Fukushima Dai-ichi Nuclear Power Plant accident in March 2011. Since then he has supported many U.S. and international efforts related to lessons learned from Fukushima. These include documenting best practices associated with data management during an international response and writing the occupational dose section of the International Atomic Energy Agency's Fukushima Report.
Dr. Blumenthal's background is in nuclear physics – gamma-ray and charged particle spectroscopy. He received his undergraduate degree in physics from Columbia College in 1985 and his doctorate in nuclear physics from Yale University in 1994. He did a post-doctoral fellowship at Argonne National Laboratory from 1994 to 1996. He became an Certified Health Physicist in 2003.
JOHN D. BOICE, JR.
is currently Professor of Medicine at Vanderbilt University School of Medicine, Nashville, Tennessee. He was President of NCRP, Bethesda, Maryland from 2012 to 2018. Dr. Boice is an international authority on radiation effects and served on the Main Commission of the International Commission on Radiological Protection for 20 y and as a U.S. advisor to the United Nations Scientific Committee on the Effects of Atomic Radiation for 25 y. During 27 y of service in the U.S. Public Health Service, Dr. Boice developed and became the first chief of the Radiation Epidemiology Branch at the National Cancer Institute.
Dr. Boice has established programs of research in all major areas of radiation epidemiology, with major projects dealing with populations exposed to medical, occupational, military and environmental radiation. These research efforts have aimed at clarifying cancer and other health risks associated with exposure to ionizing radiation, especially at low-dose levels. Dr. Boice's seminal discoveries and over 500 publications have been used to formulate public-health measures to reduce population exposure to radiation and prevent radiation-associated diseases.
He has delivered the Lauriston S. Taylor Lecture at the NCRP and the Fessinger-Springer Lecture at the University of Texas at El Paso. In 2008, Dr. Boice received the Harvard School of Public Health Alumni Award of Merit. He has also received the E.O. Lawrence Award from the Department of Energy — an honor bestowed on Richard Feynman and Murray Gell-Mann among others — and the Gorgas Medal from the Association of Military Surgeons of the United States. In 1999 he received the outstanding alumnus award from the University of Texas at El Paso (formerly Texas Western College). Dr. Boice directs the Million U.S. Radiation Workers and Veterans Study to examine the lifetime risk of cancer following relatively low-dose exposures received gradually over time.
WESLEY E. BOLCH
is Professor of Biomedical Engineering and Medical Physics in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida (UF). He serves as Director of the Advanced Laboratory for Radiation Dosimetry Studies at UF. Dr. Bolch earned his BSE degree in environmental engineering in 1984, his ME and PhD degrees in radiological physics in 1986 and 1998, respectively, from the University of Florida. He has been certified by the American Board of Health Physics since 1994 and licensed in Radiological Health Engineering by the Texas Board of Professional Engineers since 1992. In 2011, Dr. Bolch was elected Fellow of both the Health Physics Society and the American Association of Physicists in Medicine. He has been a member of the Society of Nuclear Medicine’s Medical Internal Radiation Dose (MIRD) Committee since 1993, a member of NCRP since 2005, and a member of Committee 2 of the International Commission on Radiological Protection (ICRP) since 2005. Within the latter, he serves as C2 Secretary and Leader of the ICRP Task Group on Computational Phantoms and Radiation Transport. He has published over 200 peer-reviewed journal articles, co-authored/edited 14 books/book chapters, and served as author on two NCRP reports, two ICRP publications, and two MIRD monographs.
Dr. Bolch has managed a broad research program including (1) National Institutes of Health (NIH) and U.S. Department of Energy funded projects to construct high-resolution models of the skeleton to support dose-response studies in radionuclide therapy and radiation epidemiology; (2) NIH funded projects to develop scalable NURBS-based and voxel-based computational phantoms of adult and pediatric patients and associated software for organ dose assessment in nuclear medicine, computed tomography, interventional fluoroscopy, and radiotherapy; (3) private company funded projects to develop stereotactic kilovoltage x-ray treatments for age-related macular degeneration and glaucoma; and (4) Centers for Disease Control and Prevention funded projects in stochastic modeling of worker inhalation and gamma-ray exposures following radiological accidents and potential terrorist events. He is the recipient of the 2014 Distinguish Scientific Achievement Award by the Health Physics Society acknowledging outstanding contributions to the science and technology of radiation safety.
Michael A. Boyd
is the Director of the Center for Science and Technology in the U.S. Environmental Protection Agency’s Office of Radiation and Indoor Air/Radiation Protection Division. The Center is responsible for the development of radiation dose and risk assessment guidance and for providing technical support for radiation protection policy issues. Mr. Boyd is also the co-chair of the Federal Guidance Subcommittee of the Interagency Steering Committee on Radiation Standards. He is a member of the NCRP’s PAC 5 and was recently elected to the NCRP Board of Directors. He is a member of the International Commission on Radiological Protection (ICRP) Committee 4 and chairs ICRP Task Group 98 on Application of the Commission’s Recommendations to exposures resulting from contaminated sites from past industrial, military and nuclear activities. Since 2015, he has chaired the Organisation for Economic Cooperation and Development/Nuclear Energy Agency's Committee on Radiological Protection and Public Health. Mr. Boyd is an active member of the Health Physics Society and is a delegate to the International Radiation Protection Association where he is currently a member of its International Congress Program Committee for IRPA 15, which will be held in Seoul, Korea in May 2020. He has a BS in Biology and MS in Public Health from the University of North Carolina at Chapel Hill.
RICHARD R. BREY
Professor of Health Physics, Chair Department of Nuclear Engineering and Health Physics, Director of the Idaho State University (ISU) Health Physics Program. Dr. Richard Brey received his PhD from Purdue University in Health Physics in 1994. He was the recipient of the Elda E. Anderson Award in 2002. He has engaged in a wide variety of research varying from radiation physics and detection to agricultural applications of radiation and radiation producing machines, this list importantly includes internal dosimetry; in which he has engaged in various collaborative efforts including the evaluation of historical exposures, evaluation of animal experimental data, and redefining/evaluating radioactive material translocation models. Since 1995 Dr. Brey has been the director of an environmental radioanalytical laboratory which performs approximately 1,200 sample analyses per quarter. Over the years he has served as the Director of the ISU Technical Safety Office and University Radiation Safety Officer as well as in other administrative and technical positions
BROOKE R. BUDDEMEIER
is an associate program leader in the Global Security Directorate of Lawrence Livermore National Laboratory (LLNL). He supports the Risk and Consequence Management Division in their efforts to evaluate the potential risk and consequence of radiological and nuclear terrorism. Mr. Buddemeier is a member of NCRP and served on the scientific committees which developed Commentary No. 19 - Key Elements of Preparing Emergency Responders for Nuclear and Radiological Terrorism (2005) and NCRP Report No. 165 – Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers (2010).
From 2003 through 2007, he was on assignment with the Department of Homeland Security's as the weapons of mass destruction emergency response and consequence management program manager for Science and Technology's emergency preparedness and response portfolio. He supported Federal Emergency Management Agency and the Homeland Security Operations Center as a radiological emergency response subject matter expert. He also facilitated the department's research, development, test and evaluation process to improve emergency response through better capabilities, protocols and standards. Prior to that, he was part of the LLNL Nuclear Counterterrorism Program and coordinated LLNL's involvement in the National Nuclear Security Administration's Radiological Assistance Program (RAP) for California, Nevada and Hawaii.
RAP is a national emergency response resource that assists federal, state and local authorities in the event of a radiological incident. As part of RAP's outreach efforts, Mr. Buddemeier has provided radiological responder training and instrumentation workshops to police, firefighters, and members of other agencies throughout the nation and abroad. He has also provided operational health physics support for various radiochemistry, plutonium handling, accelerator and dosimetry operations. He is Certified Health Physicist who received his Master's in Radiological Health Physics from San Jose State University and a BS in Nuclear Engineering from the University of California, Santa Barbara.
JERROLD T. BUSHBERG
is a Clinical Professor of Radiology and Clinical Professor of Radiation Oncology at University of California (UC) Davis School of Medicine. He holds the title of Director Emeritus Medical/Health Physics Programs and retired as Associate Chair of the Department of Radiology in 2018. He is currently Chair of the Board of Directors and Senior Vice President of NCRP. He is an expert on the biological effects, safety and interactions of ionizing and nonionizing radiation and holds multiple radiation detection technology patents. With over 40 y of experience he has served as a subject matter expert and an advisor to government agencies and institutions throughout the nation and around the world including the U.S. Department of Homeland Security, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health, the World Health Organization, and the International Atomic Energy Agency in the areas of ionizing and nonionizing radiation protection, risk communication, medical physics, and radiological emergency medical management. In 2016, Dr. Bushberg was appointed Vice Chair of the Committee on Man and Radiation which is a Technical Committee of the Institute of Electrical and Electronics Engineers’ Engineering in Medicine and Biology Society. Former Commander in the U.S. Naval Reserve, among other assignments CDR Bushberg served as Executive Officer of the Chemical/Biological/Nuclear Technical Unit 120 Pacific, a highly skilled multidisciplinary military emergency response and advisory team based out of the Alameda Naval Air Station in California. Dr. Bushberg is an elected fellow of the American Association of Physicists in Medicine and the Health Physics Society. He is certified by several national professional boards with specific subspecialty certification in radiation protection and medical physics and currently serves as a Director and Vice Chair of the American Board of Medical Physics. In 2014, Dr. Bushberg was awarded the NCRP Warren K. Sinclair Medal for Excellence in Radiation Science and received the Professor John C. Christiansen Distinguished Alumnus award from Purdue University School of Health Sciences in 2016. Prior to coming to the UC Davis Health System as technical director of Nuclear Medicine, Dr. Bushberg was on the faculty of Yale University School of Medicine Department of Radiology where his research was focused on radiopharmaceutical development. Dr. Bushberg has had responsibility for medical postgraduate education in medical physics, radiation (ionizing and nonionizing) biology and protection for more than 30 y. The third edition of the textbook The Essential Physics of Medical Imaging, authored by Bushberg, Seibert, Leidholdt, and Boone, is used extensively by radiology residency programs throughout the United States.
Polly Y. Chang
is the Senior Director of the Molecular and Genetic Toxicology Program in SRI International's Biosciences Division.
is the Senior Director of the Molecular and Genetic Toxicology Program in SRI International’s Biosciences Division. Dr. Chang received her BA in mammalian physiology, MA in bioradiology, and PhD in radiation biology/biophysics from the University of California, Berkeley. She is serving as the leader on a number of National Institute of Health, National Aeronautics and Space Administration, Biomedical Advanced Research and Development Authority (BARDA), and commercially sponsored projects, conducting both basic mechanistic and efficacy studies using in vitro and in vivo model systems. During her tenure at SRI, Dr. Chang has led multiple nonclinical product development programs, including vaccines, biologics, metal decorporation agents, and small molecules that have resulted in over 10 approved investigational new drug applications. She served as a co-investigator on a BARDA-funded biodosimetry project to develop a point-of-care biodosimeter for early detection of radiation exposure. The instrument is currently in the validation phase and will be moving through the Food and Drug Administration’s regulatory approval. She has served on NCRP Scientific Committee (SC) 1-20 on the biological effectiveness of low energy radiation and is currently serving on SC 1-24 on space radiation effects on the central nervous system.
C. Norman Coleman
received his BA in mathematics, summa cum laude, from the University of Vermont in 1966 and his MD from Yale University in 1970. He is board certified in three specialties — internal medicine from University of California, San Francisco; medical oncology from the National Cancer Institute; and radiation oncology from Stanford University. He served in the U.S. Public Health Service at the National Institutes of Health [O-4 (ret)]. He was Assistant and tenured Associate Professor of Radiation Oncology and Medical Oncology at Stanford and from 1985 to 1999 and Professor and Chairman of the Harvard Medical School Joint Center for Radiation Therapy. Since 1999, he has been Associate Director, Radiation Research Program and Senior Investigator, with a molecular radiation therapeutics laboratory in the Radiation Oncology Branch of National Cancer Institute. Since 2004 he has also been a Senior Medical Advisor in the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. His focus is on radiological and nuclear preparedness and planning but the programs apply to all-hazards. This includes the Scarce Resources for a Nuclear Detonation project and participation at the U.S. Embassy in Tokyo during the Japan disaster in March 2011. Among his honors are Fellowships in American College of Physicians, American College of Radiology, American Society of Radiation Oncology, and American Society of Clinical Oncology. He is recipient of an Honorary Fellowship, Royal College of Surgeons, Dublin; Honorary Fellow, Royal College of Radiologists (London); the Gold Medal from the American Society for Radiation Oncology; and the 2011 Samuel J. Heyman, Service to America Homeland Security Medal. In 2015 the University of Vermont awarded him a Doctor of Science (honoris causa) for his public service and contributions to society.
DONALD A. COOL
received his Doctorate degree in Radiation Biology from the University of Rochester School of Medicine and Dentistry. He is currently the Technical Executive for Radiation Safety at the Electric Power Research Institute (EPRI), providing advice on EPRI’s Low Dose Radiation research and various aspects of the EPRI the Radiation Safety Program. Before joining EPRI, Dr. Cool served with the U.S. Nuclear Regulatory Commission (NRC) after more than 32 y of service in a number of positions, including as Senior Advisor for Radiation Safety and International Liaison and several roles as a Senior Executive. At NRC, he was responsible for coordinating the wide range of national and international activities related to radiation protection, safety, and security of byproduct materials; decommissioning and waste management; radiation protection policy; and international radiation protection recommendations and standards. Dr. Cool is a Council Member of the National Council on Radiation Protection and Measurements (NCRP), was Co-Chair of NCRP Council Committee 1, is a member of the Main Commission of the International Commission on Radiological Protection (ICRP), Chairman of ICRP Committee 4 on Application of the Commission’s Recommendations, and is a Fellow of the Health Physics Society.
MICHAEL L. CORRADINI
is Wisconsin Distinguished Professor of Nuclear Engineering and Engineering Physics at the University of Wisconsin-Madison. He served from 1995 to 2001 as Associate Dean for the College of Engineering and as Chair of Engineering Physics from 2001 to 2011. He has published widely in areas related to vapor explosion phenomena, jet spray dynamics, and transport phenomena in multiphase systems. In 1998, he was elected to the National Academy of Engineering. He also served as a presidential appointee in 2002 and 2003 as the chairman of the Nuclear Waste Technical Review Board (a separate government agency).
From 2004 to 2008, he served as a board member of the National Accreditation Board for Nuclear Training of the Institute of Nuclear Power Operations. In 2006, he was appointed to the U.S. Nuclear Regulatory Commission's Advisory Committee on Reactor Safeguards and was elected to NCRP. Most recently, he was appointed Chair of the Scientific Advisory Committee to the French Atomic Energy Agency. He began and now serves as the Director of the Wisconsin Energy Institute. He was elected as the President of the American Nuclear Society for 2012 to 2013.
LAWRENCE T. DAUER
is Associate Attending Physicist, and Associate Clinical Member in the Departments of Medical Physics and Radiology at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. He earned an MS in Health Physics and a PhD in Adult Education. He is certified in comprehensive health physics by the American Board of Health Physics and is past chair of the Radiation Safety Committee of the American Association of Physicists in Medicine (AAPM), past President of the Greater New York Chapter of the Health Physics Society (HPS), Executive Council Member of the Medical Physics Section of the HPS, a Member of the Joint Safety Committee of the Society for Interventional Radiology and the American College of Radiology, past council member of the Radiological and Medical Physics chapter of the AAPM, and a member of editorial and review boards of several scientific journals. He serves as the Chair of the MSKCC Emergency Management Committee, a member of the Radiation Injury Treatment Network. In 2005, he received the Elda E. Anderson Award from HPS. He is a Council member and serves on he Board of Directors of the NCRP. He also serves as a member of the International Commission on Radiological Protection Committee 3 on protection in medicine, a member of the science council for the International Organization for Medical Physics, and was on the program committee for the International Atomic Energy Agency's International Conference on Radiation Protection in Medicine-Setting the Scene for the Next Decade. He serves on the Radiation Advisory Committee of the U.S. Environmental Protection Agency's Science Advisory Board. He has several publications in the topical areas of radiation protection and risks in the fields of detection, radiology, interventional radiology, x-ray imaging, nuclear medicine, and radiation oncology, as well as surgery and medicine.
is Professor in the Department of Epidemiology in the School of Public Health, at the University of Washington and a Full Member in the Program in Epidemiology of the Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center. He obtained his undergraduate degree in Biology and Chemistry from the University of New Mexico, a Master of Science in Community Health from the University of Rochester, and a PhD in Epidemiology from the University of Washington. He served as a Research Associate in Epidemiology at the Radiation Effects Research Foundation in Hiroshima, Japan, from 1983 to 1985. Dr. Davis was a Special Fellow of the Leukemia Society of American from 1986 to 1987, and the recipient of a Research Career Development Award from the National Cancer Institute from 1988 to 1993. He is an elected member of the American Epidemiological Society, and a Fellow of the American College of Epidemiology. He served as a member of the BEIR VII Committee of the National Academy of Sciences. Dr. Davis is the only foreign epidemiologist elected a member (Academician) of the Russian Academy of Medical Sciences.
Sara D. DeCair
has been with the U.S. Environmental Protection Agency (EPA) Office of Radiation and Indoor Air since 2003. She has focused on radiological emergency preparedness and spent over a decade negotiating the finalization of the 2017 EPA Protective Action Guides (PAG) Manual. Assisting with adoption of the updated PAG Manual has continued to be a collaborative effort with the Federal Radiological Monitoring and Assessment Center (FRMAC), Advisory Team for Environment, Food and Health and the Federal Emergency Management Agency, and the U.S. Nuclear Regulatory Commission. Currently, Ms. DeCair is Associate Center Director for the EPA's radiological protection program's Center for Science and Technology, a small group of radiation experts who provide federal guidance reports and lead an in-house health physics continuing education program for the Agency.
She previously worked for 7 y with the State of Michigan's Department of Environmental Quality. Three of those years were spent in nuclear power plant emergency response and planning where she went from participating in to becoming a trainer for everything from state field team leader, dose assessor, decontamination team leader, various Emergency Operations Center positions, and eventually scenario development and exercise design.
The 3 y prior, Ms. DeCair worked as a State of Michigan inspector of radioactive materials registrants and radiation incident responder. Incident responses ranged from scrap yard portal monitor alarms to oil and gas pipe yard naturally occurring radioactive material (NORM) discoveries to medical waste from Ohio or Canada. Source identification, isolation, storage, and even disposal were among the responsibilities of the incident responder. She also led the instrument calibration efforts for materials program instruments, completed several oil and gas NORM site cleanups, and facilitated the proper disposal of numerous orphan radioactive sources in the state.
Ms. DeCair is a longtime national Health Physics Society (HPS) member and has served 4 y on the Board of the Baltimore-Washington Chapter of HPS.
CHRISTINE A. DONAHUE
Christine A. Donahue was elected to NCRP in 2009 and has served on the Scientific Committees 1-18 and 1-19. She is certified in comprehensive practice by the American Board of Health Physics (ABHP), and has served on the ABHP exam development panel and as Chairperson of the Professional Development Committee. Ms. Donahue received a BS in Biophysics from University of California, Berkeley in 1981, Nuclear Engineering MS program at University of Virginia, Charlottesville in 1982, and MS in Radiological Engineering from California State University, San Jose in 1987.
Ms. Donahue is currently Director of Radiological Safety Programs at CB&I managing radiological controls and program development in support of environmental remediation efforts including Navy Base Realignment and Closure activities. Ms. Donahue was the Operational Health Physics Manager and Radiological Control Manager at the U.S. Department of Energy (DOE) Lawrence Berkeley National Laboratory in California from 1994 to 2008 responsible for site-wide radiological protection activities. She has served as a DOE lead auditor for nuclear facility readiness reviews and provided technical support to radiological safety programs at Argonne National Laboratory and Nevada National Security Site. Prior to work with DOE national laboratories, she was a senior Health Physicist at Stanford University and served as the Radiation Safety Officer at the Palo Alto Veterans Administration Hospital from 1987 to 1991. Ms. Donahue began her career in 1982 as a nuclear engineer with Bechtel National, Inc. in San Francisco and Pacific Gas & Electric where she provided health physics support during the first outage at the Diablo Canyon Nuclear Power.
JOSEPH R. DYNLACHT
is an Associate Professor in the Department of Radiation Oncology at the Indiana University School of Medicine and a member of the Experimental Therapeutics Division of the Indiana University Simon Cancer Center. He received a BS degree in Biology from Florida State University and a PhD in Cellular and Molecular Radiobiology from Colorado State University before completing a post-doctoral fellowship at the University of California, San Francisco. Dr. Dynlacht teaches a course entitled "Radiation and Cancer Biology" to radiation oncology residents and radiation therapy students annually, and is Co-director of the School of Medicine's Clinical Problem Solving course for first year medical students. He received a Trustee Award for his teaching efforts and involvement in resident training in 2012.
Dr. Dynlacht's research interests include the development of agents that reduce normal tissue damage after irradiation (specifically damage to the lens), development of radiation countermeasures, mechanisms of heat- and radiation-induced cell killing, and development of thermally-activated chemotherapeutic compounds. He has served on advisory panels for several organizations, including Brookhaven National Laboratory, the National Institutes of Health, and the National Aeronautics and Space Administration, and is currently an Associate Editor for the journal Radiation Research.
ANDREW J. EINSTEIN
is an academic cardiologist with a clinical focus on cardiac imaging and a research focus on radiation safety and medical imaging. He presently serves as both Herbert Irving Assistant Professor of Medicine (in Radiology) and Victoria and Esther Aboodi Assistant Professor of Medicine (in Radiology) at Columbia University, as well as Director of Cardiac Computed Tomography (CT) Research and Co-Director of Cardiac CT and Magnetic Resonance Imaging. He and his colleagues are involved in numerous research efforts aimed at better quantifying the radiation burden from medical imaging and interventional procedures, as well as developing and validating approaches to reduce radiation risk to patients and populations. This interdisciplinary program has been recently funded by grants from the National Heart, Lung, and Blood Institute, the Margaret Q. Landenberger Foundation, the Louis V. Gerstner, Jr. Scholars Program, and investigator-initiated grants from industry.
Dr. Einstein's research in this area has resulted in numerous publications in journals including the New England Journal of Medicine, JAMA, and The Lancet. This work has been influential in affecting clinical practice, has been widely reported in the popular media and cited over two thousand times in the scientific literature. For this work, he has received the Louis Katz Cardiovascular Research Prize for a Young Investigator, the American Federation for Medical Research's Junior Physician Investigator Award, and the American College of Cardiology's Douglas P. Zipes Distinguished Young Investigator Award. In addition to his work on NCRP, Dr. Einstein is a member of the Food and Drug Administration's Medical Imaging Drugs Advisory Committee and a consultant to the International Atomic Energy Agency.
He is a board member of the American Society of Nuclear Cardiology, the Association for Clinical and Translational Science, and the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging, and serves on the editorial boards of several cardiology journals. He has served as a Special Scientific Advisor to the Radiation Effects Research Foundation in Hiroshima Japan, a corresponding member of the International Commission on Radiological Protection Task Group 62 on Radiological Protection in Cardiology, and a reviewer for the National Cancer Institute and over 20 journals. Dr. Einstein received an AB from Princeton University in mathematics, an MS from Columbia University in biostatistics/patient oriented research, and MD and PhD degrees from Mount Sinai School of Medicine.
K. Frieda Fisher-Tyler
directs the Office of Radiation Control in the Delaware Division of Public Health, which regulates the use of ionizing radiation sources in the State of Delaware. She is certified in comprehensive practice by the American Board of Industrial Hygiene, and worked as an Industrial Hygienist, Radiation Safety Officer, and Environmental Health and Safety Director in the chemical and pharmaceutical industries prior to transitioning to state service in 2002. She serves as the governor-appointed U.S. Nuclear Regulatory Commission State Liaison Officer and Alternate Commissioner for the Appalachian States Commission for Low Level Radioactive Waste for Delaware. She leads the Technical Assessment Team for the Delaware Radiological Emergency Preparedness Program managed by Delaware Emergency Management Agency, and acts as Administrative Agent to the governor-appointed Delaware Authority on Radiation Protection. She served on the Board of Directors of the Conference of Radiation Control Program Directors (CRCPD) from 2010 to 2013, chairing the Homeland Security/Emergency Response Council for the Board, and represents the CRCPD on the Governmental Coordinating Council - Nuclear Sector managed by the U.S. Department of Homeland Security, Critical Infrastructure Protection. She served on the Board of Directors of the American Board of Industrial Hygiene from 2000 to 2003, serving a term as Board Vice Chair. She received her MHS degree from the Environmental Engineering Department, Bloomberg School of Public Health, Johns Hopkins University, and her BS degree from the Institute of Environmental Health, Colorado State University. She resides in Magnolia, Delaware.
is a Senior Health Physicist in the Office of Federal and State Materials and Environmental Management Programs at the U.S. Nuclear Regulatory Commission (NRC). In this position, she serves as office lead for safety culture activities and is also a member of the working group tasked with developing the regulatory basis for the revisions to the radiation protection regulations (10 CFR Part 20). She joined NRC in 2004 and served as the Team Leader of the Medical Radiation Safety Team for 5 y. Ms. Flannery has 20 y experience as a health physicist in the medical industry as well as in military and research organizations. Prior to NRC, she served as Branch Chief and Radiation Safety Officer for the Defense Threat Reduction Agency and as the Radiation Safety Officer/Health Physicist at the Food and Drug Administration. Before her employment by the federal government, she worked as a Health Physics Consultant and as a Nuclear Medicine Technologist. Ms. Flannery graduated from Georgetown University with an MS in Health Physics and from the University of Wisconsin with a BS in Nuclear Medicine Technology. She was certified by the American Board of Health Physics in 2001. She currently serves as Chair of the American Board of Health Physics Part I Examination Panel.
PATRICIA A. FLEMING
is Professor Emerita in Philosophy at Saint Mary’s College, Notre Dame having retired as its Provost. She resides in Logandale, Nevada, one of the areas which experienced fallout from the above ground nuclear testing in the 1950s. She received her master’s and doctorate from Washington University in St. Louis, Missouri. While there, she served as the assistant editor of the Philosophy of Science Journal. She has also served as a consultant to the Organization for Economic Co-operation and Development/Nuclear Energy Agency in Paris, France. Dr. Fleming has published and lectured internationally on the ethical and epistemological issues associated with the disposal of high-level nuclear waste, including the use of expert elicitation methodology in site characterization, waste management and indigenous populations, informed consent in stakeholder populations, and circularity in regulatory policy. Dr. Fleming’s familiarity with ethical concerns regarding the health effects from radiation exposure led to her appointment on the National Academy of Science Committee to Assess the Scientific Information for the Radiation Exposure Screening and Education Program. She served on the Veterans Board on Dose Reconstruction from 2005 to 2013. Her current project is a manuscript on ethics and the wide gamut of nuclear matters.
Donald P. Frush
is Professor of Radiology at Lucile Packard Children’s Hospital at Stanford. Dr. Frush received a BS from The University of California Davis, MD from Duke University, was a pediatric Resident at University of California San Francisco from 1985 to 1987, a radiology resident at Duke, and finished a pediatric radiology fellowship at Children’s Hospital Medical Center in Cincinnati in 1992.
Dr. Frush’s research interests are predominantly focused on pediatric body computed tomography (CT), including technology assessment, techniques for pediatric multidetector computed tomography examinations, assessment of image quality, and CT radiation dosimetry and dose reduction. International affiliations include the World Health Organization and the International Atomic Energy Agency. Dr. Frush is currently a board member of the Society for Pediatric Radiology as well as NCRP, Chair of the Image Gently Alliance, Trustee of the American Board of Radiology, and a current Fellow of Society of Computed Body Tomography and Magnetic Resonance.
ERIC M. GOLDIN
is radiation safety specialist with 35 y of experience in power reactor health physics. He earned a BS in Nuclear Engineering from The University of Arizona and an MS in Nuclear Engineering/Health Physics from Texas A&M University. He completed a PhD in Biomedical Sciences at the University of Texas Graduate School of Biomedical Sciences, Houston. Dr. Goldin has been a member of NCRP Program Area Committee 2 since 2004, participating in report writing for Scientific Committees 46-17, 2-4, 2-5, and 2-7. He is an active member of the Health Physics Society (HPS), served on the Board of Directors, several committees and sections, and on the American Board of Health Physics (ABHP).
Dr. Goldin has been certified by the ABHP since 1984 and was awarded HPS Fellow status in 2012. Dr. Goldin's radiological engineering experience includes ALARA (as low as reasonably achievable) programs, instrumentation, radioactive waste management, emergency planning, dosimetry, decommissioning, licensing, effluents, and environmental monitoring. In addition, he taught graduate/upper division level courses in radiation biology, radiological assessment, and power reactor health physics at San Diego State University for over 20 y and assisted in the development and implementation of a Radiation Protection Technician training program at MiraCosta College. Dr. Goldin retired from Southern California Edison in 2012 and currently provides technical support and decommissioning planning to the San Onofre Nuclear Generating Station.
Eric J. Grant
is the Associate Chief of Research at the Radiation Effects Research Foundation (RERF) in Hiroshima and Nagasaki, Japan. Dr. Grant received his BSEE from the University of Michigan and his PhD in Epidemiology from the University of Washington. He worked as a computer programmer for the University of Michigan Medical Center prior to coming to RERF where he served in several positions prior to his current post.
RERF's mission is to study the long-term health effects due to radiation exposure to the atomic bombings. Dr. Grant's research has focused on solid cancer risks of radiation exposure. He has also published on hormonal changes among women after whole-body exposure, and on the lack of evidence of trans-generational mortality effects of radiation exposure among the children of the atomic-bomb survivors.
Dr. Grant is the principle investigator of a project bringing Master- and PhD-level students to RERF to complete projects using RERF data. This outreach program has been successful in recruiting students to radiation-related research positions. Dr. Grant is also working to improve data sharing policies to improve collaborative research opportunities with students and scientists around the world.
HELEN A. GROGAN
is President of Cascade Scientific, Inc., an environmental consulting firm. Dr. Grogan received her PhD from Imperial College of Science and Technology at the University of London in 1984 and has more than 25 y of experience in radioecology, environmental dose reconstruction, and the assessment of radioactive and nonradioactive hazardous wastes. She first worked at the Paul Scherrer Institute in Switzerland on the performance assessment of radioactive waste disposal for the Swiss National Cooperative for the Disposal of Radioactive Waste (Nagra). Dr. Grogan was actively involved in the early international cooperative efforts to test models designed to quantify the transfer and accumulation of radionuclides and other trace substances in the environment.
Validation of computer models developed to predict the fate and transport of radionuclides in the environment remains a key interest of hers. In 1989 Dr. Grogan returned to the United Kingdom as a senior consultant to Intera Information Technologies before moving to the United States a few years later, where she has worked closely with Risk Assessment Corporation managing the technical aspects of a wide variety of projects that tend to focus on public health risk from environmental exposure to chemicals and radionuclides. Dr. Grogan has served on committees for the National Academy of Sciences, the International Atomic Energy Agency, the U.S. Environment Protection Agency, and NCRP. She co-edited the text book Radiological Risk Assessment and Environmental Analysis published by Oxford University Press in July 2008, and authored the chapter on Model Validation.
Barbara L. Hamrick
is the Radiation Safety Officer at the University of California (UC), Irvine Health. Prior to joining the UC Irvine Health team, Ms. Hamrick spent nearly 20 y as a health physicist in regulatory agencies, including the U.S. Nuclear Regulatory Commission, Los Angeles County Radiation Management, and the California Department of Public Health.
Ms. Hamrick currently serves on the U.S. Environmental Protection Agency’s Radiation Advisory Committee, which advises the Scientific Advisory Board on matters of radiation protection, radiation science, and radiation science applications. She served as Chair of the Organization of Agreement States (2005 to 2006), as President of the Health Physics Society (2014 to 2015), and as a committee member of the National Academies of Sciences Committee on Lessons Learned from Fukushima (2012 to 2016).
Ms. Hamrick received a BS and MS in physics from UC Irvine, in 1985 and 1987, respectively. She earned a law degree in 1999 from Loyola Law School in Los Angeles and is an active member of the California State Bar. In 2002, Ms. Hamrick was certified by the American Board of Health Physics.
Willie O. Harris
is the Director, Radiation Protection for Exelon Nuclear. In his current role he is responsible to develop the governance and provide oversight of the radiation protection programs for the largest operator of nuclear power plants in the United States. He has over 35 y of broad-based experience in commercial nuclear power plants, which includes over 25 y in supervisory and management positions. He holds a bachelor’s degree in radiation protection and a master degree in business administration. He is a Certified Health Physicist and a registered radiation protection Technologist and holds a senior reactor operator certification. He continues to serve several industry committees which includes the Scientific Advisory Committee for the Electric Power Research Institute (EPRI) Low Dose Research, the EPRI Technical Advisory Committee, and the World Nuclear Association Radiation Protection Working Group.
Lawrence H. Heilbronn
is the John D. Tickle Associate Professor in the Nuclear Engineering Department at the University of Tennessee, Knoxville. He is an experimental nuclear physicist with over 30 y of experience in conducting experiments at accelerators around the world. His expertise is in the field of measuring secondary neutron production cross sections and yields of interest in the field of radiation protection. His current areas of research are in the field of secondary particle production from heavy ion interactions relevant to space radiation protection, radioisotope production for medical, security, and power applications, and nuclear thermal propulsion systems. He teaches undergraduate and graduate courses in radiation protection, health physics, space radiation, isotope production, and radioisotope power systems.
Dr. Heilbronn has published over 130 articles in peer-reviewed journals. He currently leads several federally funded research projects and mentors several graduate and undergraduate students. He is a member of the American Physical Society, the American Nuclear Society, the American Society for Engineering Education, the Institute of Electrical and Electronics Engineers, and the Health Physics Society. Dr. Heilbronn received a BS in physics from the University of Montana, an MS in physics from the University of Illinois, and a PhD in physics from Michigan State University. Before coming to the University of Tennessee in 2008, he worked at Lawrence Berkeley National Laboratory.
KATHRYN D. HELD
became President of the NCRP in January 2019. She held the position of Executive Director and Chief Science Officer from 2016 to 2018. She was first elected to the Council in 2006 and served on the NCRP Board of Directors from 2008 to 2014. She was Vice President from 2011 to 2016 of Program Area Committee 1 on Basic Criteria, Epidemiology, Radiobiology, and Risk. She also served as Chair of the Program Committee for the 2011 Annual Meeting on “Scientific and Policy Challenges of Particle Radiations in Medical Therapy and Space Missions.” Dr. Held was a member of Scientific Committee (SC) 1-22 on Radiation Protection for Astronauts in Short-Term Missions and Phase I of SC 1-24 on Radiation Exposures in Space and the Potential of Central Nervous System Effects and an advisor to several NCRP committees.
Dr. Held is an Associate Radiation Biologist in the Department of Radiation Oncology, Massachusetts General Hospital (MGH) and Associate Professor of Radiation Oncology (Radiation Biology) at Harvard Medical School (HMS). At MGH, Dr. Held leads a team that is involved in research on molecular mechanisms for the induction of bystander effects by high energy particles in cells and tissues, characterization of charged particle beam induced DNA damage responses and cell killing, development of a cancer screening platform for personalized radiation medicine, and mechanisms for regulation of DNA damage response by cell-cell communication. Dr. Held also teaches radiation biology to radiation oncology medical and physics residents and graduate students at MGH/HMS and the Massachusetts Institute of Technology.
Dr. Held earned her PhD in biology from the University of Texas, Austin. She has served on review panels for numerous federal agencies including the National Institutes of Health, the National Aeronautics and Space Administration (NASA), and the U.S. Army Medical Research and Material Command programs and other organizations such as the Radiological Society of North America. She is on the Editorial Boards of Radiation Research and the International Journal of Radiation Biology, and has served on committees for the National Academy of Science/National Research Council, NASA, and the American Society of Radiation Oncology. She is a past President of the Radiation Research Society.
Kathryn A. Higley
Kathryn A. Higley is a Professor and Head of the School of Nuclear Science and Engineering in the College of Engineering at Oregon State University. Dr. Higley received both her PhD and MS in Radiological Health Sciences from Colorado State University, and her BA in Chemistry from Reed College. She has held both Reactor Operator and Senior Reactor Operator's licenses, and is a former Reactor Supervisor for the Reed College TRIGA reactor. Dr. Higley started her career as a Radioecologist for Portland General Electric. She later worked for Pacific Northwest National Laboratory as a Senior Research Scientist in the area of environmental health physics. Dr. Higley has been at Oregon State University since 1994 teaching undergraduate and graduate classes on radioecology, dosimetry, radiation protection, radiochemistry, and radiation biology.
Her fields of interest include environmental transport and fate of radionuclides, radioecology, radiochemistry, radiation dose assessment, neutron activation analysis, nuclear emergency response, and environmental regulations. She is vice-chair of the International Commission on Radiological Protection's Committee 4 (Application of the Commission’s Recommendations); a fellow of the Health Physics Society and a Certified Health Physicist.
E. Vincent Holahan
is a radiation biologist with a specialization cellular and molecular biology. He has BS degrees in chemistry and biology from Gonzaga University and a PhD in radiology and radiation biology from Colorado State University. He has been a member of the Radiation Research Society since 1978. He currently is employed by the U.S. Nuclear Regulatory Commission (NRC) and is the Senior Level Technical Advisor for Health Physics in the Office of Nuclear Material Safety and Safeguards. In this position he is responsible for performing risk assessment analyses designed to improve the knowledge of actual and potential radiological impacts of NRC licensed facilities and activities. In conjunction with NCRP and the National Research Council/National Academy of Sciences (NRC/NAS), he assists in the development of the technical basis for initiating, planning and issuing new federal regulations and guidance to limit exposure to ionizing radiation from licensed byproduct material in order to protect public health and safety and the environment.
Dr. Holahan's activities include service as a technical advisor to the U.S. delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation since 2000. He also has served as the NRC delegate to the Nuclear Energy Agency (NEA) Committee on Radiation Protection and Public Health and as the past Vice Chairman to the NEA Information System on Occupational Exposure. Dr. Holahan also represents the United States at the International Atomic Energy Agency's (IAEA) Radiation Safety Standards Committee and provides technical support to the IAEA Radiation Safety and Monitoring Section. Prior to joining the NRC in 1996, Dr. Holahan served as a Senior Program Officer to the Board on Army Science and Technology at NRC/NAS and as a member of the U.S. Army. During his 35 y of service in the U.S. Army and Army Reserve, COL (retired) Holahan was assigned to a variety of positions as a nuclear medical sciences officer and is a U.S. Department of Defense certified Master Consequence Management Specialist for chemical, biological, radiological, nuclear, and high explosive events.
ROGER W. HOWELL
is a Professor of Radiology at Rutgers New Jersey Medical School where he serves as Chief of the Division of Radiation Research. Dr. Howell's laboratory conducts research on dosimetry and radiobiology of internal radionuclides, with emphasis on the microscopic dose distributions encountered in nuclear medicine. He also studies the capacity of vitamins and other natural agents to protect reproductive organs, bone marrow, and the gastrointestinal tract against damage caused by ionizing radiation.
These efforts have led to over 100 publications in peer-reviewed journals. Dr. Howell teaches physics to radiology residents and provides educational lectures for emergency responders in New Jersey. He has served on review panels for federal agencies including the National Institutes of Health, the U.S. Department of Energy, and other organizations. Dr. Howell is a member of the Medical Internal Radiation Dose Committee of the Society of Nuclear Medicine and Molecular Imaging, He has served on several report committees of the International Commission on Radiation Units and Measurements (ICRU) and was elected to the ICRU Main Commission in May 2014. Dr. Howell earned his BS and PhD in Physics from the University of Massachusetts, Amherst.
Janice L. Huff
is a scientist at the National Aeronautics and Space Administration (NASA) Langley Research Center in Hampton, Virginia where she works on space radiation risk modeling, countermeasure approaches and technologies supporting human space exploration missions. She previously served as the Deputy Element Scientist for the NASA Space Radiation Element at the Johnson Space Center and was responsible for scientific management and strategic planning, ensuring that the Element’s research portfolio was organized to understand and mitigate radiation health risks for the astronaut corp. She was a visiting scientist at the Brookhaven National Laboratory and is an experienced user of the NASA Space Radiation Research Laboratory where her research work centered on evaluation of the effects of charged particle radiation on cancer processes using advanced human three-dimenstional cell culture models. She joined NASA in 2004 as the lead scientist for the Advanced Technology Development Laboratory in the Cell Science Program.
Dr. Huff has held the positions of research assistant professor at the University of Nevada, Las Vegas, where she studied integrin-mediated cancer cell migration and metastasis, and was also a research scientist at Bioforce Nanosciences, Inc., a bio-nanotechnology company specializing in development of ultraminiaturized biodiagnostic tools and technologies. She received a BS in Microbiology and a BA in Psychology from the University of Rochester, and earned a PhD in Microbiology from the University of Virginia studying molecular biology, oncogenes and signal transduction in the laboratory of J. Thomas Parsons.
Dr. Huff was elected to the NCRP in 2017, was a member of Scientific Committee (SC) 1-24P2: Radiation Exposures in Space and the Potential of Central Nervous System Effects, and currently serves on SC 1-27: Evaluation of Sex-Specific Differences in Lung Cancer Radiation Risks and Recommendations for Use in Transfer and Projection Models. She was a member of the Organizing Committee for the 2019 and 2020 NCRP Annual Meetings.
Adam R. Hutter
is the Director of the National Urban Security Technology Laboratory (NUSTL), a government-owned and government-operated lab of the U.S. Department of Homeland Security’s (DHS) Science & Technology Directorate. Dr. Hutter is the seventh permanent Director in the lab’s 65+ year history.
Under Dr. Hutter’s leadership, NUSTL conducts programs to test, evaluate and assess homeland security technologies and systems specifically for First Responders to effectively transition new capabilities into operational use. In addition, NUSTL conducts and sponsors research and development in the field of radiological and nuclear response and recovery.
Dr. Hutter started federal service in 1987 at the U.S. Department of Energy’s Environmental Measurements Laboratory. Career highlights include serving as a Subject Matter Expert on International Atomic Energy Agency missions in Russia and Kazakhstan, leading U.S. government delegations to transfer characterization, monitoring and sensor technologies from the Former Soviet Union academies, research institutes, and Nuclear Complex facilities, and serving as a Technical Advisor to federal, state, and local governments on the integration of counterterrorism technologies into everyday to use to help ensure the nations safety and security. As a federal executive and leader, Dr. Hutter develops and maintains strong partnerships among federal, state and local government agencies in support of the homeland security mission.
Among Dr. Hutter’s honors are the Meritorious Service Award from the DHS/Domestic Nuclear Detection Office (DNDO) and three separate DHS Awards for Leadership, Program Management, and a team award for Science & Technology. He was nominated for The Samuel J. Heyman Service to America Medals for Career Achievement. Dr. Hutter earned a BS degree from the University of Delaware, an MS degree from the Pennsylvania State University, and a PhD from the City University of New York. He has advanced his leadership and executive skills at Harvard University and the Center for Creative Leadership.
Randall N. Hyer
Randall N. Hyer, Senior Fellow and Assistant Director for Environmental, Health and Safety, Center for Risk Communication.
Dr. Hyer graduated with distinction from the U.S. Naval Academy, and served 12 y on active duty in the U.S. Navy. After earning his medical degree from Duke University, Dr. Hyer served as the 40th Winter-Over Medical Officer and Assistant Officer-in-Charge with Operation DEEP FREEZE at McMurdo and South Pole Stations in Antarctica. Dr. Hyer earned his PhD from Oxford, studying the molecular genetics of juvenile diabetes and helped determine the role of the insulin gene in disease susceptibility.
In 1994, the National Institutes of Health awarded Dr. Hyer the "NIH Outstanding Research Award for Clinical Trainees." Trained in public health at Walter Reed Hospital and Harvard University, Commander Hyer supported four major military operations in the European, African, and southwest Asian theatres to include service as Chief Public Health Advisor for the Kosovo operations and Deputy Surgeon for the Mozambique flood relief operations. Dr. Hyer then spent 4 y at the World Health Organization (WHO) in Geneva as the first WHO Civil Military Liaison Officer and served as part of the WHO's outbreak response team to deadly outbreaks like anthrax, SARS, and avian influenza as well as having organized missions during the 2005 Tsunami response. His experiences with the media in outbreaks and emergencies led him to coauthor the popular WHO handbook, Effective Media Communication During Public Health Emergencies.
Appointed a U.S. Congressional Fellow for Senator Pete V. Domenici (R-New Mexico), he helped introduce legislation to safeguard genetic privacy that eventually became the Genetic Information Non-discrimination Act (GINA) of 2008. In 2005, Dr. Hyer joined Merck Vaccine Division in Global Medical Affairs and Policy. His focus has been the human papilloma virus (HPV) vaccine. In 2009, he was transferred to MSD in Tokyo, Japan.
WILLIAM E. IRWIN
leads the Radiological and Toxicological Sciences Program at the Vermont Department of Health and is responsible for radiation protection in medicine and other applications, nuclear facility environmental surveillance, preventive radiological/nuclear detection and emergency preparedness. He is a member of NCRP Council Committee 1 which produced Report No. 180, Management of Exposure to Ionizing Radiation: Radiation Protection Guidance for the United States (2018); Program Area Committee 3, Scientific Committee (SC) 3-1 which wrote Report No. 179, Guidance for Emergency Response Dosimetry; and SC 3-1P2 which wrote Commentary No. 27, Implications of Recent Epidemiologic Studies for the Linear-Nonthreshold Model and Radiation Protection, for implementation of Report No. 179. He was on the 2017 NCRP Annual Meeting Program Committee and presented on the gaps filled in emergency response by the Radiological Operations Support Specialist (ROSS). He helped lead the NCRP Special Session on Radioactive Waste Management at the 2018 Health Physics Society (HPS) Mid-Year Meeting and serves on the 2019 NCRP Annual Meeting Program Committee. Dr. Irwin represents the Conference of Radiation Control Program Directors (CRCPD) on the ROSS Steering Committee leading efforts to train and certify hundreds of ROSS to bolster national radiological and nuclear preparedness. He is a ROSS instructor for Counter Terrorism Operations Support and reinforces his responder capabilities as a Chief Officer of the Vermont Hazardous Materials Response Team, and as a Chief Officer and Emergency Medical Technician for the Bakersfield Volunteer Fire Department. He is a Certified Health Physicist, long-time member of HPS and was previously on the American Board of Health Physics Part II Panel of Examiners. He serves the CRCPD in numerous committees, was on its Board of Directors and served as the Board Chair. Prior to government service, Dr. Irwin worked as Laser Safety Officer and Radiation Safety Officer at Harvard University and the Massachusetts Institute of Technology. He is a consultant on radiofrequency radiation (RFR), laser radiation, extremely low frequency electromagnetic fields, nuclear magnetic resonance fields, and ionizing radiations. He volunteers for Interpol in its international efforts to prevent and detect the smuggling of radiological and nuclear materials. Both his Doctor of Science and Master of Science were earned at the University of Massachusetts Lowell with his dissertation on the health effects of wireless telecommunications RFR exposure. Dr. Irwin started in nuclear power, first as a radiation protection technician on U.S. Navy submarines, guided missile cruisers, and aircraft carriers at Newport News Shipbuilding and Dry Dock Company and then as an instructor and supervisor in radiation protection, chemistry, and nuclear power plant systems and operations training at commercial facilities.
Thomas E. Johnson
Associate Professor, Health Physics, Colorado State University, has performed extensive research and taught in diverse areas of radiation safety including environmental, medical, and uranium mining over the last 15 y. He has authored or co-authored over 30 peer reviewed papers, three books, mentored over 30 graduate students, and is responsible for teaching five graduate classes. He has been the principal investigator for multiple research projects funded by the U.S. Department of Defense, the U.S. Nuclear Regulatory Commission, the U.S. Department of Energy, the U.S. Department of Agriculture, the National Institute for Occupational Safety and Health, and other agencies.
Dr. Johnson's work seeks to understand how contaminants move in the environment, the impact on biota and humans. Currently, he is focused on examining the environmental impact of the Fukushima Daiichi reactor accident and coordinating student research in the area. This work directly applies to his other area of interest, uranium mining and its impact on the environment.
CYNTHIA G. JONES
is currently the Senior Level Advisor for Materials, U.S. Nuclear Regulatory Commission (NRC), Washington, DC, where she serves as NRC Commissioner Caputo’s lead technical expert for major materials policy, program or operational issues associated with nuclear safety, radiation protection, accident and radiological consequence analyses, security, safeguards, advanced reactor design, and international policy. From 2012 to 2016, Dr. Jones worked at the U.S. Mission to International Organizations in Vienna, Austria as the U.S. Mission’s expert and Nuclear Safety Attaché on nuclear safety issues and programs providing programmatic and policy oversight for the United Nation and the International Atomic Energy Agency’s (IAEA) safety programs on behalf of the United States. In 2013, she was asked by IAEA to serve as an invited expert in the development of IAEA’s comprehensive report on Tokyo Electric Power Company’s Fukushima Daiichi Accident. With experience as a physicist, health physicist, and nuclear engineer, Dr. Jones has extensive international experience in both radiation safety and nuclear security, and has more than 97 publications, reports or speeches in the fields of nuclear science and radiological protection. In 2011, she was elected as one of 100 scientific experts worldwide to serve as an NCRP Council member.
Before joining NRC, Dr. Jones worked as a physicist at the National Bureau of Standards, and held positions as both a reactor and medical physicist at the University of California, Los Angeles, and the Oak Ridge Institute for Science and Education. Dr. Jones has a PhD and an MS in Nuclear Engineering from the University of Maryland, an MS degree in Health Physics from the Georgia Institute of Technology, and a Bachelor’s degree in Physics from Augsburg College, Minneapolis, Minnesota. She includes German as her foreign language.
Ziad N. Kazzi
trained in Emergency Medicine at Emory University in Atlanta (2000 to 2003) where he served as a Chief Resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham from 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an Associate Professor at the Department of Emergency Medicine at Emory University in Atlanta as well as the Director of the International Toxicology Fellowship Program at Emory University. He is also the Assistant Medical Director of the Georgia Poison Center and a Guest Researcher at the National Center for Environmental Health at the CDC where he participates in emergency preparedness and response activities in radiation.
As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage and management of poisonings and holds a deep interest in the areas of radiation and international toxicology. He founded and chaired the American Academy of Clinical Toxicology Radiation Interest Group since 2009. He is currently serving as a Board Member of the American College of Medical Toxicology (ACMT) and the Medical Toxicology Foundation. He chairs the ACMT Clerkship Council and International Committees. Dr. Kazzi has extensively lectured at national and international conferences and developed several curricula and training programs in emergency preparedness and response. He is an active and founding Board Member of the Middle East North Africa Toxicology Association and currently serves as its President.
WILLIAM E. KENNEDY, JR.
has extensive experience as a project manager, task leader, and individual contributor covering a broad range of health physics and nuclear engineering topics. He received his BS and MS degrees in Nuclear Engineering from Kansas State University. Mr. Kennedy has been involved in the development of environmental pathway and radiation dosimetry models used to assess potential health and environmental impacts that resulted from releases of radionuclides to the environment.
He specializes in the use of these models in environmental dose reconstruction, radioactive materials transport, radioactive waste disposal, and evaluation of nuclear facility operating practices. Over the past 37 y, Mr. Kennedy has led and contributed to a variety of projects for the U.S. Nuclear Regulatory Commission, the U.S. Department of Energy, the Electric Power Research Institute, and private industry. He has been involved with development of the technical basis for revised standards and regulations, and serves as the chair of ANSI/HPS N13.12, Surface and volume Radioactivity Standards for Clearance. He served as a consultant to the International Atomic Energy Agency (IAEA), Vienna, Austria, and was a member of the IAEA Advisory Groups to evaluate the Derivation of Exempt Quantities for Application to Terrestrial Waste Disposal and Derivation of Exempt Quantities for Recycle of Materials from Nuclear Facilities.
He was an invited lecturer for IAEA training courses on Management of Radioactive Waste from Nuclear Power Plants at Argonne National Laboratory; on Safety Assessment Modeling for Low and Intermediate Radwastes in Rio de Janeiro, Brazil and in Cairo, Egypt; and on Environmental Monitoring in Kiev, Ukraine. In 1990, he received the Health Physics Society's (HPS) prestigious Elda E. Anderson Award. He served as a member of the HPS Board of Directors from 1998 through 2001 and was selected as a fellow of the society in 2002. He was a member of the U.S. delegation to the 10th Congress of the International Radiation Protection Association in Hiroshima, Japan.
KATHERINE A. KIEL
is a Professor of Economics at the College of the Holy Cross in Worcester, Massachusetts. Her research is on real estate price indices, racial discrimination in housing markets, and the demand for environmental quality in the United States. Her work has been published in journals such as Land Economics and the Journal of Urban Economics. She is currently a board member for the New England Economic Partnership and is on the Board of Economic Advisors for Associated Industries of Massachusetts. In the past she served on the U.S. Environmental Protection Agency's Advisory Council on Clean Air Compliance. She received her PhD in Economics from the University of California at San Diego and her AB from Occidental College.
Gladys A. Klemic
is a physicist with the National Urban Security Technology Laboratory (NUSTL), a federal resource of the U.S. Department of Homeland Security which supports the development of technologies for emergency response agencies. She designs and conducts laboratory tests of radiation detectors, and operational field evaluations of prototype and commercially available equipment for firefighter and law enforcement agencies. She is active in national standards development and has been with NUSTL and its predecessor, the Environmental Measurements Laboratory since 1990. Her earlier work specialized in environmental thermoluminescence dosimetry, including conducting dosimeter research, measurements and analysis, and leading international intercomparisons. She has authored or co-authored 40 scientific and technical publications and is a member of the Health Physics Society and the National Fire Protection Association. She has a BS degree in Physics from Wayne State University and an MS degree in Physics from New York University.
Linda A. Kroger
is Assistant Clinical Professor of Radiology at the University of California (UC) Davis School of Medicine and has served as the Radiation Safety Officer for the UC Davis Health System for the past 16 y. Ms. Kroger received her undergraduate degree and her Master’s Degree from Rutgers University. She has been with UC Davis for 25 y. Prior to her arrival at UC Davis, Ms. Kroger worked for private industry in biopharmacology research and drug development. She transitioned to cancer research when she joined UC Davis in 1988. From 1988 through 2000, her research focused on the development of new radiopharmaceuticals for both diagnostic imaging and treatment of non-Hodgkin’s lymphoma and breast cancer. Since assuming her role as Radiation Safety Officer in 2003, she has focused on regulatory compliance, quality assurance issues as well as education of medical students, residents and fellows with the overall goal of improving workplace radiation safety. Ms. Kroger oversees the nonclinical aspects of nuclear medicine training for the radiology residency program at UC Davis. In addition, she has taken an interest in radiologic emergency preparedness. Ms. Kroger has authored or co-author more than 50 peer-reviewed journal articles and has presented at numerous scientific conferences. She has served in a number of roles in both the local chapter as well as the national Health Physics Society and been an active participant on NCRP committees since 2005.
is a staff biophysicist at the Lawrence Berkeley National Laboratory (LBNL). Her research focuses on fundamental processes that may result in genomic change following exposure to sparsely or densely ionizing radiation. Her group has also addressed links between molecular mechanisms of DNA damage repair and programmed cell death. Dr. Kronenberg teaches radiation biophysics to students at the National Aeronautics and Space Administration Space Radiation Summer School. Dr. Kronenberg received her ScD in Cancer Biology from the Harvard School of Public Health. She has served on review panels for federal agencies and international scientific review panels. She is a senior editor for Radiation Research and is also a member of the editorial board of the Journal of Radiation Research (Japan). Dr. Kronenberg's activities with NCRP have included prior service on the Board of Directors, as a member or chair of the Nominating Committee, and as a member of several scientific committees. She was recently an invited speaker at the 2011 Annual Meeting and is currently a member of NCRP Program Area Committee 1.
Evagelia C. Laiakis
received her PhD degree in Human Genetics from the University of Maryland at Baltimore, studying radiation induced genomic instability and the contribution of pro-inflammatory processes under the guidance of Dr. William F. Morgan. She subsequently completed her postdoctoral fellowship with Dr. Albert J. Fornace, Jr. at Georgetown University, in the field of radiation biodosimetry through metabolomics. She is currently an Associate Professor in the Department of Oncology at the Lombardi Comprehensive Cancer Center and the Department of Biochemistry and Molecular and Cellular Biology. She is an elected Council Member to NCRP and has been serving as a member of Program Area Committee 1 of NCRP since 2016. She is also a current Councilor-at-Large of the Radiation Research Society (RRS) and a dedicated mentor to students and postdocs in various societies and the Sallie Rosen Kaplan fellowship program. Dr. Laiakis’ lab aims to expand the field of radiation metabolomics and lipidomics through mass spectrometry with untargeted and targeted approaches. Her research focus includes understanding metabolic responses to scenarios involving a wide range of doses (low dose to acute radiation syndrome associated doses), dose rates, normal tissue responses, and radiation quality effects (photons; neutrons; high atomic number, high energy particles), utilizing biofluids and tissues from rodents to humans. Her work has also expanded to space radiation effects, in combination with stressors such as microgravity, with emphasis on immune and muscle related changes. Finally, she is an Associate Editor for the International Journal of Radiation Biology and the 2019 recipient of the Jack Fowler award from RRS.
JOHN J. LANZA
is the Director of the Florida Department of Health in Escambia County (FDOH-EC). Dr. Lanza is a Board-certified pediatrician with a PhD in Medical Radiation Physics from the University of Florida. Since 2001, he has been the Public Health and Medical co-chair for the Florida Department of Law Enforcement's Domestic Security Task Force Northwest Florida. Before his FDOH-EC position, Dr. Lanza worked as a pediatric emergency department physician in Lakeland, Florida and was in private pediatric practice in Longwood, Florida. Dr. Lanza is a fellow of the America Academy of Pediatrics, a past president of the Escambia County Medical Society (2004), a member of the American Medical Association, and the Florida Medical Association (FMA), where he was the chair of the FMA Council on Public Health for 8 y. He is a founding board member of the Florida Public Health Institute. In addition, he is a member of the Florida Chapter of the Health Physics Society and the national Health Physics Society where he serves as past president of their Homeland Security Section and a member of the medical response subcommittee. Dr. Lanza was recently elected to the Health Physics Society Board of Directors. In 2005, he was appointed as a Florida Commissioner on the Southeast Compact Commission for Low-Level Radioactive Waste Management. Currently, he is on the faculty of the Master of Public Health program at the University of West Florida's (UWF) School of Allied Health and Life Sciences as well as holding faculty positions at UWF's Department of Health, Leisure, and Exercise Science, and the Center for Environmental Diagnostics and Bioremediation (CEDB). With the CEDB, he was the co-principal investigator on the Centers for Disease Control and Prevention and the U.S. Environmental Protection Agency funded projects dealing with local environmental health issues.
In addition, he led an 8 y research project on human health effects of toxins such as dioxin from local Superfund sites. Dr. Lanza is also a clinical assistant professor in the Department of Clinical Sciences at the Florida State University College of Medicine. Dr. Lanza serves on the Residency Advisory Committee for the joint U.S. Army and Navy Aerospace Medicine Residency Program at Naval Air Station Pensacola. Dr. Lanza has numerous publications in the fields of health physics, environmental health, and public health preparedness. Most recently, he was a member of the NCRP scientific committee that produced Report No.165,"Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers."
EDWIN M. LEIDHOLDT, JR.
is currently the Director of the National Health Physics Program, Veterans Health Administration (VHA), U.S. Department of Veterans Affairs (VA). His areas of interest include technical quality assurance and radiation dose management in medical imaging. He is a diplomate of the American Board of Radiology in Medical Nuclear Physics and Diagnostic Radiological Physics and is a Fellow of the American College of Radiology. He received a PhD in Nuclear Engineering, a Master of Applied Mathematics, a Master of Engineering in Nuclear Engineering, and a BS in Nuclear Engineering, all from the University of Virginia. He has served as a Radiation Safety Officer at two VA medical centers, as technical director of nuclear medicine at one, as the Radiation Safety Program Manager for the former VHA Western Region, and as Program Manager for the VHA National Health Physics Program. He is a Clinical Associate Professor of Radiology at the University of California, Davis. He is a co-author of several scientific papers and abstracts, one textbook chapter, and one textbook, in its third edition. He has been a Council member since 2006. He served on the scientific committee that wrote NCRP Report No. 165, Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers, and on the committee that prepared NCRP Statement No. 11. Dr. Leidholdt served as a surface line officer in the U.S. Navy from 1971 until 1975.
Mark P. Little
joined the National Cancer Institute, Radiation Epidemiology Branch (REB) in 2010 as a Senior Investigator. He studied mathematics at Trinity College, Cambridge and obtained his doctorate in mathematics at New College, Oxford. Over the last two decades he has been analyzing cancer and cardiovascular disease risks in the Japanese atomic-bomb survivors, and in other irradiated populations and offspring. Previously (2000 to 2010), he worked in Imperial College London, and before that (1992 to 2000) at U.K. National Radiological Protection Board (now part of Public Health England). He is a member of NCRP, and has served as consultant to the United Nations Scientific Committee on the Effects of Atomic Radiation, to the International Atomic Energy Agency, to the International Committee on Radiological Protection (ICRP) (in particular as member of ICRP Task Group 91), to the U.K. Committee on the Medical Aspects of Radiation in the Environment, and to a recently formed NCRP Scientific Committee 1-26. In REB, Dr. Little is working on assessment of leukemia risk in persons exposed at low doses and dose rates, cancer risk in various cohorts of persons exposed as result of the Chernobyl accident, on risks of various health endpoints in the U.S. cohort of radiologic technologists, and on treatment-related second cancer risks in various populations. He has particular interest in dose measurement error models, with application to assessment of low-dose and low-dose-rate risk of childhood leukemia and circulatory disease.
PAUL A. LOCKE
a public health scientist and attorney, is an Associate Professor at the Johns Hopkins University Bloomberg School of Public Health in the Department of Environmental Health Sciences, Division of Molecular and Translational Toxicology. He holds an MPH from Yale University School of Medicine, a DrPH from the Johns Hopkins University Bloomberg School of Public Health, and a JD degree from Vanderbilt University School of Law.
Dr. Locke's research and practice focus on how decision makers use environmental health science (toxicology, radiobiology, epidemiology) in regulation and policy making and how environmental health sciences influence the policy-making process. His areas of study include radiation risk communication, designing and evaluating radiation protection initiatives and radiation policies, radon risk reduction, safe disposal of high level radioactive waste, and use of computed tomography as a diagnostic screening tool. Dr. Locke directs the School's Doctor of Public Health program in Environmental Health Sciences.
Dr. Locke was a member of the National Academy of Sciences (NAS) Nuclear and Radiation Studies Board from 2003 to 2009. He has served on seven National Academy committees, and is currently a member of an NAS committee that is tasked with providing an assessment of lessons learned from the Fukushima nuclear accident for improving the safety and security of nuclear plants in the United States. He is also a member of the Board of Directors of NCRP. He was program committee chair of the NCRP's 2010 annual meeting entitled "Communication of Radiation Benefits and Risks in Decision Making." Dr. Locke is admitted to practice law in the state of New York, the District of Columbia, the Southern District Court of New York, and the United States Supreme Court.
Alan G. Lurie
Alan G. Lurie is professor and chair of the Division of Oral and Maxillofacial Diagnostic Sciences and chair of the Section of Oral and Maxillofacial Radiology, Department of Oral Health and Diagnostic Sciences, at the University of Connecticut School of Dental Medicine. He has John Dempsey Hospital appointments in the Departments of Dentistry and Diagnostic Imaging and Therapeutics. He has been a full-time member of the dental school faculty since 1973, during which time he has done R0-1 research on radiation carcinogenesis, administered predoctoral and graduate educational programs, performed clinical research, and performed imaging care on patients in both dental and medical radiology settings.
He is past president and a current member of the School of Dental Medicine Council, co-founder of the University of Connecticut Multidisciplinary Head and Neck Cancer Clinic, and a member of numerous dental school and institutional committees. He is also an active member of his specialty nationally, having served as Councilor for Public Policy and Scientific Affairs of the American Academy of Oral and Maxillofacial Radiology, and Past President of the American Board of Oral and Maxillofacial Radiology. Dr. Lurie has more than 100 publications in the refereed literature, and numerous presentations to local, state, national and international organizations.
is the Professor of Radiology and Medicine at the Johns Hopkins University School of Medicine, Baltimore, Maryland. He is also the Chief Physicist at the Johns Hopkins Hospital in Baltimore. He is also the Professor of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health.
Dr. Mahesh obtained his PhD in Medical Physics from Medical College of Wisconsin, Milwaukee. Dr. Mahesh is board certified from the American Board of Radiology in diagnostic radiological physics and is a member of the Radiation Control Advisory Board for the State of Maryland. His research interests are in medical imaging, particularly in areas of multiple-row detector computed tomography (MDCT), interventional fluoroscopy, and digital mammography. As chief physicist, he oversees the quality assurance program for the diagnostic radiology that includes maintaining compliance with regard to state and federal regulations and ensuring safe use of radiation to patients. He often provides counsels to patients concerned over their radiation exposure from diagnostic x-ray examinations.
Dr. Mahesh is the editor of the Physics Columns (Technology Talk and Medical Physics Consult) for the Journal of American College of Radiology (JACR) since 2007. He is also the Associate Editor of JACR, Deputy Editor for Academic Radiology, Editorial Board Member for RadioGraphics and Radiology journals. He is the Treasurer for the American Association of Physicists in Medicine (AAPM) and board member of the Society of Cardiovascular Computed Tomography (SCCT). He is a fellow of the AAPM (2007), ACR (2009), American College of Medical Physics (2011), and SCCT (2011).
Dr. Mahesh has been invited to be the United Nations-International Atomic Energy Agency (UN-IAEA) expert to participate in IAEA activities. Dr. Mahesh is the author of the textbook titled MDCT Physics: The Basics – Technology, Image Quality and Radiation Dose. He publishes and lectures extensively here in the United States and internationally in the area of MDCT technology, radiation doses in medical imaging, and other medical physics areas.
Dr. Mahesh is on the NCRP Council and was a member of NCRP Scientific Committee (SC) 6-2 that published NCRP Report No. 160, Ionizing Radiation Exposure of the United States Population. He is the co-chair of NCRP SC 4-9 on Medical Exposure of the U.S. population.
RUTH E. MCBURNEY
is the Executive Director of the Conference of Radiation Control Program Directors. In that position, she manages and directs the administrative office for the organization. Prior to taking that position in January 2007, she was the Manager of the Radiation Safety Licensing Branch at the Texas Department of State Health Services, culminating 25 y of service in the Texas Radiation Control Program, most of which involved licensing and standards development.
Ms. McBurney has served on the U.S. Nuclear Regulatory Commission's Advisory Committee on the Medical Use of Isotopes and the U.S. Food and Drug Administration's National Mammography Quality Assurance Advisory Committee. She is currently serving as a Member of NCRP, and is also on the Board of Directors. She served as a consultant to the International Atomic Energy Agency in the categorization of radiation sources and recently served on a committee of the National Academy of Science regarding replacement technologies for high-risk radiation sources. She has also been a U.S. delegate to the International Radiation Protection Association's 10th, 11th, 12th, and 13th Congresses.
Ms. McBurney holds a BS in Biology from Henderson State University in Arkansas and an MS in Radiation Sciences from the University of Arkansas for Medical Sciences. She is also certified in comprehensive health physics by the American Board of Health Physics.
Michael T. Milano
is a board certified radiation oncologist who practices at the University of Rochester Medical Center. He attended the University of Rochester for medical school and graduate school, and holds a PhD in biophysics. His residency training was at the University of Chicago. He is currently an Associate Professor, Director of the Residency Program in Radiation Oncology and Director of the Stereotactic Radiotherapy Program. He has clinical expertise in the radiotherapy of thoracic malignancies as well as benign and malignant tumors of the central nervous system. Dr. Milano’s clinical research has been devoted to investigating the clinical outcomes of patients treated with newer technologies, as well as the treatment of patients with oligometastatic disease. Additional research interests include cancer survivorship, with a focus on second malignancies and late effects of cancer therapy. He has served on committees for the American Society of Radiation Oncology and American Association of Physicists in Medicine.
DONALD L. MILLER
is Chief Medical Officer at the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health. He earned a BA from Yale University and an MD from New York University, and completed a residency in diagnostic radiology and a fellowship in interventional radiology at New York University Medical Center. He is board certified in Diagnostic Radiology and Vascular and Interventional Radiology. Prior to joining FDA, he practiced interventional radiology at the National Institutes of Health and the National Naval Medical Center in Bethesda, Maryland.
Dr. Miller was elected to NCRP in 2006. He currently serves on the Board of Directors, as Chair of Program Area Committee 4 (Radiation Protection in Medicine), and as a member of several Scientific Committees. He is an author of NCRP Reports No. 168 and No. 172 and Statement No. 11. He served as a member of International Commission on Radiological Protection (ICRP) Committee 3 (Protection in Medicine) from 2010 to 2017. He is an author of ICRP Publications 117, 120, 135, and 139. He was Vice-Chair for the U.S. Environmental Protection Agency’s Federal Guidance Report No. 14, is a consultant to the International Atomic Energy Agency, and is a member of the World Health Organization’s Core Group of Experts on Radiation Protection of Patients and Staff.
Dr. Miller was Professor of Radiology at the Uniformed Services University in Bethesda, MD from 1993 to 2012 and has served as Associate Editor of Radiology and the Journal of Vascular and Interventional Radiology. He is an author of more than 185 papers in peer-reviewed journals and more than 30 book chapters and reports, is a Fellow of the Society of Interventional Radiology (SIR) and the American College of Radiology (ACR) and is an Honorary Member of the American Association of Physicists in Medicine. He chaired SIR’s Safety and Health Committee from 1999 to 2011 and the ACR Guidelines Interventional Committee from 2008 to 2012. His research interests have centered on radiation protection in medicine.
STEPHEN V. MUSOLINO
is a scientist in the Nonproliferation and National Security Department at the U. S. Department of Energy's (DOE) Brookhaven National Laboratory (BNL) in Upton, New York. With more than 30 y of experience in Health Physics, his current research interests are in nonproliferation, counterterrorism, and planning for response to the consequences of radiological and nuclear terrorism. Since 1981, he has been part of the DOE Radiological Assistance Program as a Team Captain/Team Scientist and has been involved in developing radiological emergency response plans and procedures, as well as participating in a wide range of radiological and nuclear exercises and field deployments. During the Fukushima crisis, he was deployed in Japan as an Assessment Scientist with the DOE response team that was measuring the environmental consequences of the radioactive material released from the damaged nuclear power plants. Working with the first responder community in the New York metropolitan area, Dr. Musolino was involved with the development of guidance for response to the aftermath of a radiological dispersal device, and served on the scientific committee that developed NCRP Report No. 165, Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers. Earlier in his career at BNL, he was a member of the Marshall Islands Radiological Safety Program and participated in numerous field missions to monitor the populations living on islands affected by nuclear testing.
Dr. Musolino is a Fellow of the Health Physics Society, Distinguished Alumnus of Buffalo State College, and a member of the editorial board of the journal Health Physics. He earned a BS in engineering technology from Buffalo State College, an MS in nuclear engineering from Polytechnic Institute of New York University, and a PhD in health physics from the Georgia Institute of Technology. He is certified by the American Board of Health Physics.
WAYNE D. NEWHAUSER
is the Director of the Medical and Health Physics Program at Louisiana State University in Baton Rouge, holder of the Dr. Charles M. Smith Chair in Medical Physics, and Chief of Physics at the Mary Bird Perkins Cancer Center. He is a board certified and licensed medical physicist with specialization in advanced-technology radiotherapies. Dr. Newhauser is an expert in proton radiation therapy, dose reconstructions, and risk estimation and reduction. His current research projects seek to improve long-term outcomes of survivors of childhood and adult cancers. He and his multidisciplinary team of collaborators are known for their early use of Monte-Carlo methods and high-performance computing in proton therapy, including neutron shielding, treatment planning, and estimation of stray radiation exposures. He received the Innovation Excellence Award in 2012 in recognition of his laboratory's research involving in-silico clinical trials to compare advanced-technology radiotherapies.
Dr. Newhauser has published more than 85 peer-reviewed journal articles, leads federal research grants, and mentors graduate students and post-doctoral fellows. He has served in leadership roles in the American Association of Physicists in Medicine, the American Nuclear Society, and the Health Physics Society. He serves on the International Advisory Board of the journal Physics In Medicine and Biology and is a corresponding member of EURODOS. After receiving a BS in nuclear engineering and MS and PhD degrees medical physics from the University of Wisconsin, he worked at the German National Standards Laboratory, Harvard Medical School and Massachusetts General Hospital, and The University of Texas MD Anderson Cancer Center.
Michael A. Noska
is the Senior Advisor for Health Physics, the Agency Radiation Safety Officer, and the Team Lead for Radiological Emergency Response at the U.S. Food and Drug Administration (FDA). He has been a health physicist with the U.S. Public Health Service (PHS) for 21 y and has had multiple assignments at the National Institutes of Health and the FDA with a focus on internal radiation dosimetry and radiological emergency preparedness and response. Prior to joining the PHS, Captain Noska worked as a research assistant in radiopharmaceutical laboratories at Harvard Medical School and Duke University Medical Center developing radiolabeled monoclonal antibodies for the treatment of cancer. He received his MS from the University of North Carolina School of Public Health as a Department of Energy Applied Health Physics Fellow. Captain Noska is the current Chair of the Federal Advisory Team for the Environment, Food and Health and a member of the Federal Radiological Preparedness Coordinating Committee. He is also the Past Chair of the Environmental Health Officer Professional Advisory Committee to the U.S. Surgeon General and Past President of the Baltimore-Washington Chapter of the Health Physics Society. Captain Noska serves on several interagency committees and workgroups related to radiological emergency response. In 2011, he deployed to Japan as part of a team from the U.S. Department of Health and Human Services in support of the U.S. Ambassador following the Great Tohoku Earthquake and the nuclear crisis at the Fukushima Dai-ichi Nuclear Power Station.
is the Director of Physics Research at the Department of Radiation Oncology at Massachusetts General Hospital and a Professor of Radiation Oncology at Harvard Medical School. He received his PhD in experimental nuclear physics in 1992 from the Rheinische-Friedrich-Wilhelms University in Bonn, Germany, and has been working in radiation therapy research on experimental as well as theoretical aspects since 1994. He is internationally recognized as an authority on proton therapy and specifically on Monte-Carlo simulations of dose and biological effects, the latter including modeling of clinical relative biological effectiveness as well as late effects. He has authored and co-authored more than 120 peer-reviewed publications and has edited a book on Proton Therapy Physics. For his research leadership he received the 2013 A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School. Dr. Paganetti has been awarded numerous research grants from the National Cancer Institute.
He serves on the editorial boards for the International Journal of Radiation Oncology, Biology, Physics as well as Technology in Cancer Research and Treatment. He is a member of numerous task groups and committees for various associations such as the American Association of Physicists in Medicine. Notably he is a member of the Radiation Physics Committee of the American Society for Therapeutic Radiology and Oncology. From 2009 to 2012 he was the Science Chair of the International Organization for Medical Physics. He is also a member of the Radiation Therapeutics and Biology Study Section at the National Cancer Institute.
Christopher N. Passmore
currently holds the position of Vice President of Dosimetry Services at Landauer. Mr. Passmore has more than 26 y of experience in all aspects of dosimetry and radiological protection fields. He is an internationally known expert in dosimetry, radiation monitoring, radiation field characterization, regulatory compliance, and accreditation programs. He has technical responsibility for Landauer’s world leading analytical dosimetry laboratory, including analysis, dose reporting, regulatory compliance, quality control, engineering, and manufacturing. Mr. Passmore also holds the positons of Landauer’s Head of the Approved Dosimetry Services in Canada, United Kingdom, and Ireland. He is a member of the Nagase-Landauer and Beijing – Landauer Board of Directors.
Mr. Passmore serves as a U.S. delegate and technical expert to the International Electrotechnical Commission (IEC) TC45 and International Organization for Standardization (ISO) TC85, where he has been involved in influencing and developing several critical dosimetry standards (IEC 62387, ISO 21099, ISO 15690, ISO 15382, and ISO 14146) and was recently appointed to an ISO Ad Hoc Committee to develop standards on Population Monitoring Following Radiological Accidents. In addition to international standard committees he also serves as a member of the Health Physics Society Standard Committee.
Prior to joining Landauer, Mr. Passmore worked for 10 y in the U.S. Department of Energy (DOE) nuclear weapons complex managing external and internal dosimetry programs at Rocky Flats Plant (plutonium and uranium facility) and Pantex (nuclear weapon assembly/disassembly). Mr. Passmore was also appointed as assessor for the DOE Laboratory Accreditation Program in 1993 and fulfilled this role until joining Landauer in the fall of 2000.
Mr. Passmore holds an MS degree in Health Physics from National Technological University, a BS in Nuclear Engineering from Arizona State University, and a BS degree in both Physics and Engineering from Illinois College. He is also certified in Comprehensive Health Physics by the American Board of Health Physics.
DAVID J. PAWEL
is Statistician in the U.S. Environmental Protection Agency (EPA) Office of Radiation and Indoor Air. His current focus is a reassessment of the EPA radiogenic cancer risk estimates. He is a co-author of the "Blue Book" on EPA's most recent radiogenic risk models and an EPA technical report on its assessment of risks from radon in homes. In 2003, as the second Beebe Fellow, he studied methods to improve cancer-specific radiogenic risk estimates at the Radiation Effects Research Foundation (RERF) in Hiroshima, Japan and the National Cancer Institute in 2004.
Dr. Pawel was a member of the RERF Statistics Department from 1992 to 1994. He is a member of NCRP and served on its committee on uncertainties in internal dose estimates. He has a BS in Mathematics from the College of William and Mary, an MS in Statistics from Rutgers University, and a PhD in Statistics from the University of Wyoming.
Leticia S. Pibida
has a PhD in Physics from the University of Tennessee, Knoxville. She works at the National Institute of Standards and Technology (NIST). She has served as a research scientist for low-level radioactivity measurements using laser ionization mass spectrometry. She performs gamma-ray spectrometry measurements to develop standard reference materials as well as calibration of radioactive sources for source manufacturers, radiopharmaceutical companies, and nuclear power plants. Since 2002 her work involves testing of commercially available radiation detection instruments and development of national and internal standard for radiation instrumentation used for detection of illicit trafficking of radioactive materials and homeland security applications. She is an NCRP member since 2018, the American National Standards Institute N42 Committee chair, and the convener of the International Electrotechnical Commission TC45 WG9 and SC45B WGB15. She is the author of over 70 peer reviewed papers and over 110 reports, standards, and conference proceedings.
KATHRYN H. PRYOR
has been a member of Program Area Committee (PAC) 2 since 2007 and a member of NCRP since 2010. She has served on Scientific Committees 2-4, 2-5, 2-7, 1-19, and 6-9. Ms. Pryor is currently on the NCRP Board of Directors and is Scientific Vice President of PAC 2. She received her BS in Biology in 1979 and MS in Radiological Sciences in 1981, both from the University of Washington.
Ms. Pryor was the Chief Health Physicist at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington, providing management and technical support to the PNNL Radiation Protection Division since 1992. She also served as the Chief Radiological Engineer for the design of the Pit Disassembly and Conversion Project. Ms. Pryor previously held radiation protection technical support positions at the San Onofre Nuclear Generating Station and the Trojan Nuclear Plant, and was the Radiation Safety Officer at the University of Southern California Health Sciences Campus.
Ms. Pryor is a Fellow member of the Health Physics Society (HPS) and served as President-Elect, President, and Past President from 2010 to 2013. She is certified in comprehensive practice by the American Board of Health Physics (ABHP), and served on the ABHP both as a member and Chair from 1998 to 2002. She is currently the President of the American Academy of Health Physics. Ms. Pryor was awarded the William McAdams Outstanding Service Award by ABHP in 2007 and the John P. Corley Meritorious Service Award by the Columbia Chapter of HPS in 2003.
Mark J. Rivard
is a Professor of Radiation Oncology at Brown Medical School in Providence and a clinical medical physicist with internationally-recognized expertise in brachytherapy dosimetry. He has championed this treatment modality within the American Association of Physicists in Medicine, the American Brachytherapy Society, the American Society for Radiation Oncology, and the European Society for Radiotherapy and Oncology through numerous board appointments, committee assignments, and task group chairmanships. Dr. Rivard serves on radiotherapy editorial boards in leadership roles specific to clinical medical physics, and has received substantial extramural support for his various research programs. Through these efforts, he has innovated several medical devices for advancing patient care.
is a Senior Service Fellow in the Radiation Studies Branch in the National Center for Environmental Health, Centers for Disease Control and Prevention. Prior to this appointment, Dr. Salame-Alfie spent 22 y with the New York State Department of Health in various capacities including Director of the Division of Environmental Health Investigation, Director of Preparedness for the Center for Environmental Health, and Director of the Bureau of Environmental Radiation Protection.
Dr. Salame-Alfie is a member of NCRP and co-chairs the SC 3-1 charged with developing dosimetry guidance for radiation emergency workers. She is a Lifetime member of the Conference of Radiation Control Program Directors where she served as Chair and member of the Board of Directors, and chaired several committees. She is a Fellow member of the Health Physics Society.
Dr. Salame-Alfie has extensive experience in radiological emergency preparedness and has published and co-authored many publications on the subject, including the Handbook for Responding to a Radiological Dispersal Device – First Responder Guide.
Dr. Salame-Alfie obtained her Master’s and Ph.D. in Nuclear Engineering from Rensselaer Polytechnic Institute in Troy, New York.
DEBRA M. SCROGGS
is Manager of Environmental Radiation Monitoring and Assessment at the Department of Health, Olympia, Washington. She received a B.S. in Physics and an M.S. in Radiological Sciences from the University of Washington. She is certified by the American Board of Health Physics. Her interests include policy and government relations and homeland security. She is a member and past chair of the Conference of Radiation Control Program Directors and received their James Miller Award. She is also a member of the Health Physics Society and has served on several committees.
J. ANTHONY SEIBERT
is Professor of Radiology at the University of California (UC) Davis School of Medicine in Sacramento, California. He received a PhD in Radiological Sciences from UC Irvine in 1982, specializing in quantitative digital fluoroscopic imaging. Directly thereafter, he took a faculty position at UC Davis Medical Center, pursuing digital imaging research, physics education efforts for graduate students and radiology residents, as well as quality control for medical imaging equipment in Diagnostic Radiology. He has continuing academic interests in digital mammography, computed tomography, interventional radiology, imaging informatics, and radiation dose tracking, assessment, and reporting. Former president of the American Association of Physicists in Medicine (AAPM) in 2011 and current Governor of the American Board of Radiology, Dr. Seibert has served and continues to interact with many professional committees in regards to medical imaging issues and presenting technical / educational events for the AAPM, International Atomic Energy Agency, and other professional societies. For NCRP, he is a member of Program Area Committee 4. As a co-author of The Essential Physics of Medical Imaging textbook for diagnostic physics education, Dr. Seibert continues with the development of cutting edge imaging technologies and medical physics education to improve the state of imaging science for the betterment of patient care.
Kathleen L. Shingleton
is retired from Lawrence Livermore National Laboratory where she was employed for more than 38 y in a variety of positions in the Radiation Safety Program. Throughout her career she was involved with the Health Physics Society (HPS), serving as Treasurer, a Director, and Venues Committee Chair; the American Academy of Health Physics (AAHP), serving as the President and Secretary; the American Board of Health Physics, serving on both the Part I and Part II exam panels; and the Northern California Chapter of the HPS where she held numerous positions. In 2007 she was selected as a Fellow of HPS. In 2017 she became a member of the National Council on Radiation Protection and Measurements and currently serves on the Finance Committee and Program Area Committee 2. She has a BS degree from Virginia Polytechnic Institute and State University, a Master’s Degree in Health Physics from San Jose State University, and is comprehensively Certified by the ABHP.
is a member of the U.S. Environmental Protection Agency's (EPA) Center for Radiation Information and Outreach. Ms. Shogren's career with EPA has focused on radiation risk communication and radiation data visualization. Ms. Shogren supported EPA's communication efforts during the 2011 Fukushima Daiichi nuclear accident. She has facilitated international panels on radiation risk communication in pediatric medical imaging, with a focus on patient advocacy and effective communication methods. Since 2010, Ms. Shogren has been a member of an expert working group led by the World Health Organization that addresses radiation risk communication in pediatric medical imaging. With her guidance, this group developed the 2016 practical reference document, Communicating Radiation Risk in Paediatric Medical Imaging: Information to Support Healthcare Discussions About Benefit and Risk.
is an assistant professor in the Center for Radiological Research, Department of Radiation Oncology at Columbia University Medical Center. His research interests focus on mechanistic mathematical modeling of the effects of ionizing radiation on living organisms. They include modeling of radiation-induced carcinogenesis at both low and high doses (e.g., second cancers induced by radiotherapy for primary malignancies), cancer therapy (e.g., tumor control and normal tissue complications), nontargeted ("bystander") effects of radiation (e.g., for densely-ionizing radiation exposures such as those occurring on manned space missions), and mechanisms of resistance to ionizing radiation in human and nonhuman cells.
Dr. Shuryak's training and experience have been interdisciplinary, starting with biology (BA from Columbia University) and medicine (MD from State University of New York Downstate College of Medicine). He received a PhD degree with distinction from the Department of Environmental Health Sciences (Columbia University, Mailman School of Public Health) for work on combing both short- and long-term time scales in mechanistic modeling of radiation-induced carcinogenesis.
STEVEN L. SIMON
received a BS in Physics from the University of Texas, an MS in Radiological Physics from the University of Texas Health Sciences Center in Dallas, and a PhD in Radiological Health Sciences from Colorado State University. Early in his career, he worked in medical physics and was the first treatment planner for clinical trials of treatments of solid tumors with negative pi-mesons at the Los Alamos Physics Meson Facility. Later specializing in environmental radioactivity, he directed the first nationwide monitoring program of the Marshall Islands for residual contamination from nuclear testing. He also participated in the radiological monitoring of numerous other nuclear test sites worldwide including Johnston Island, French Polynesia, and Algeria and has lead, or participated in, health risk studies of fallout exposures in Utah, the Marshall Islands, and Kazakhstan.
In 2000, Dr. Simon joined the National Cancer Institute's Radiation Epidemiology Branch as an expert in dose reconstruction and presently heads the Dosimetry Unit in that group. Steve is a member of NCRP and has been an Associate Editor of Health Physics for 20 y. In 2011 during the Fukushima crisis, Steve was deployed by the U.S. Department of Health and Human Services to the U.S. Embassy in Japan to assist with the protection of American citizens.
David C. Spelic
is a physicist with the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health. On his arrival at the FDA in 1994, Dr. Spelic became involved with the Agency’s implementation of the Mammography Quality Standards Act (MQSA), particularly focusing on mammography physics testing and the training of MQSA inspectors.
Presently Dr. Spelic conducts premarket reviews of diagnostic x-ray devices, and directs most technical aspects of the Nationwide Evaluation of X-Ray Trends (NEXT) program, an FDA collaboration with the Conference of Radiation Control Program Directors to document trends in patient dose and image quality for selected diagnostic x-ray exams and procedures.
MICHAEL D. STORY
is a professor at the University of Texas (UT) Southwestern Medical Center, Dallas. Dr. Story earned his PhD from Colorado State University. He holds the David A. Pistenmaa, MD, PhD Distinguished Chair in Radiation Oncology, serves as Vice-Chair of the Department of Radiation Oncology, Chief of the Division of Molecular Radiation Biology, and Director of the Pre-clinical Radiation Core Facility. Dr. Story serves on the editorial board of Mutagenesis and the International Journal of Particle Therapy and has served on a number of review panels for the National Cancer Institute (NCI), the National Aeronautics and Space Administration (NASA), and other entities.
Dr. Story directs the radiobiology course for the Medical Physics graduate program and the Radiation Oncology medical resident program and was a faculty member for NASA’s Space Radiation Summer School. Dr. Story's research is focused on five areas associated with radiation exposure: (1) delineating the effects of novel superoxide dismutase compounds that can act as both radioprotector and radiosensitizer in the same setting; (2) understanding and exploiting the biological effects of tumor treating fields in combination with radiation and/or chemotherapy agents; (3) developing biomarkers of the radioresponse of lung and liver tissues to high linear-energy transfer radiation exposures, including the development of biomarkers of carcinogenic risk; (4) enhancement of carbon ion radiotherapy for pancreatic and head and neck cancers; and (5) identification of genomic or epigenomic factors that predict or are prognostic for the radioresponse in head and neck squamous cell carcinoma. Dr. Story's research is funded by NCI, NASA, the Cancer Prevention and Research Institute of Texas, and industry.
Glenn M. Sturchio
Dr. Sturchio is the Radiation Safety Officer for the Mayo Clinic facilities in Jacksonville, Florida and Rochester, Minnesota supporting the use of radiation sources in the clinical, research and education areas. In addition, he is an Assistant Professor of Physiology in the Mayo College of Medicine; his teaching duties include two courses in the Graduate School and a course in the School of Health Sciences.
Dr. Sturchio is the Section Manager, Medical and Operational Health Physics on the ANSI N13 committee that develops American National Standards Institute / Health Physics Society standards. Dr. Sturchio received his PhD from the School of Public Health at the University of Minnesota and is certified in the comprehensive practice of health physics by the American Board of Health Physics.
Julie M. Sullivan
is a biologist at the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health where she reviews medical devices involved in radiation therapy to ensure their safe and effective use. She is also involved in FDA working groups related to medical countermeasures against radiation exposure. Prior to joining the FDA, Dr. Sullivan was an American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow and contractor in the U.S. Department of Health and Human Services’ Office of Emergency Management under the Assistant Secretary for Preparedness and Response. There, she helped develop nationwide response plans for radiological and nuclear incidents and focused on the operational needs for the use of biodosimetry. Prior to working for the government, Dr. Sullivan was a post-doctoral associate at Duke University where her research focused on elucidating the role of p53 in the hematopoietic and gastrointestinal Acute Radiation Syndromes. Dr. Sullivan received her BS in Chemistry from the State University of New York Geneseo and her PhD in Biological Chemistry from the University of North Carolina at Chapel Hill.
STEVEN G. SUTLIEF
is currently a medical physicist with the Banner MD Anderson Cancer Center in Phoenix, Arizona and an adjunct professor at San Diego State University. He received his PhD in experimental particle physics from the University of Washington and subsequently completed a post-doctoral fellowship in radiation therapy medical physics at the University of Washington with research in intensity modulated radiation therapy. He has been chief medical physicist at the Veterans Affairs (VA) Puget Sound Health Care System in Seattle and an affiliate faculty member in the University of Washington School of Medicine, a professor at the University of California San Diego and a medical physicist with Landauer Medical Physics. Dr. Sutlief worked to advance radiation therapy within the VA, including agency-wide radiotherapy equipment modernization, radiotherapy device interconnectivity, consultation for the VA National Health Physics Program, participation in several investigations, and development of qualification standards for therapeutic medical physicists. He has coauthored more than 50 articles and book chapters related to therapeutic medical physics. Dr. Sutlief developed and taught the physics curriculum for the Bellevue College Medical Dosimetry program. He has served as a consultant to the International Atomic Energy Agency and as a member of the Radiation Oncology planning group for the Integrating the Healthcare Enterprise. Dr. Sutlief was a Co-organizer for the AAPM Summer School on Quality and Safety in Radiation Therapy and was a faculty member for the Veterans Health Administration Biennial Conference on Radiation Oncology. He actively participates in the American Association of Physicists in Medicine, where he has served on many committees and on several task group reports. He is currently an NCRP Council member.
TAMMY P. TAYLOR
has served as the Director of the International Data Centre (IDC) Division of the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO) since August 2018. The IDC collects, processes and analyses monitoring data originating from the facilities of the International Monitoring System (IMS). Processing and analysis results are then presented as lists of events, bulletins and reports to Member States as a central element of the CTBT verification mechanism. Based on this information, States are enabled to make judgments about ambiguous events. Before joining the CTBTO, Dr. Taylor served as the Chief Operating Officer of the National Security Directorate at the Pacific Northwest National Laboratory (PNNL) where she led the mission execution, capability development, and project management of the directorate of three divisions and four project management offices. Prior to joining PNNL in 2013, she served in a number of positions over 15 y at Los Alamos National Laboratory (LANL). Dr. Taylor served in positions as the Deputy Associate Director of Chemistry, Life and Earth Sciences, the Division Leader of Nuclear Engineering and Nonproliferation, a group leader, project leader, staff member and Director’s Postdoctoral Research Fellow. From early 2007 to mid-2010 she was an Intergovernmental Personnel Act assignee from LANL in the Office of Science and Technology Policy (OSTP) in the Executive Office of the President. She managed the national science and technology portfolio on nuclear defence issues within the National Security and International Affairs Directorate of OSTP for Dr. John Holdren and Dr. Jack Marburger, Science Advisors to President Obama and President Bush, respectively. Dr. Taylor has an MS and PhD in Environmental Engineering from the Georgia Institute of Technology. Her undergraduate degree in Civil Engineering is from New Mexico State University.
JULIE E.K. TIMINS
is a Diagnostic Radiologist, board certified in General Radiology and in Nuclear Medicine. Her medical practice has been varied, including Chair of Nuclear Medicine at the Veterans Administration Hospital in Lyons, New Jersey; Staff Radiologist at Robert Wood Johnson University Hospital and St. Peter’s Medical Center, New Brunswick, New Jersey; diagnostic imaging in an inner-city hospital in Jersey City; and Mammography and Women’s Imaging in an outpatient facility in Morristown, New Jersey. Dr. Timins is Chair of the New Jersey Commission on Radiation Protection, and sits on the New Jersey Radiologic Technology Board of Examiners. She served on the NCRP Board of Directors and has participated on several Annual Meeting Program Committees. She is past president of the Radiological Society of New Jersey and recipient of that organization’s Gold Medal Award. Dr. Timins is a Fellow of the American College of Radiology (ACR) and former member of the Council Steering Committee. She served as Vice-Chair for Practice Guidelines and Technical Standards of the ACR Commission on Quality and Safety. She is a recipient of the Advisory Committee Service Award of the U.S. Food and Drug Administration, in recognition of distinguished service on the National Mammography Quality Assurance Advisory Committee. The American Association for Women Radiologists has honored Dr. Timins with the Professional Leadership Award for Mid-Career/Senior Faculty and the President’s Award. In appreciation of service as an Affiliate Member of the Conference of Radiation Control Program Directors, she was presented with the Board of Directors Award for Outstanding Achievement in the Field of Radiation Protection, for participation on the H-30 Task Force and development of the White Paper on Bone Densitometry.
Sergei Y. Tolmachev
is an Research Professor in the College of Pharmacy, Washington State University (WSU), where he directs the U.S. Transuranium and Uranium Registries (USTUR) Research Center and the National Human Tissue Repository (NHRTR). The USTUR/NHRTR is a federal-grant-funded human tissue research program providing long-term follow-up of actinide biokinetics and potential health effects in nuclear workers (volunteer registrants) with accidental internal depositions of actinide elements. Prior to the directorship, Dr. Tolmachev managed the USTUR's radiochemistry laboratory operations and research in the fields of actinide radiochemistry and mass spectrometry, in support of internal dosimetry and actinide biokinetics research.
Dr. Tolmachev is a member of the Board of Directors of the Herbert M. Parker Foundation at WSU. He serves on the Editorial Board of the Japanese Journal of Health Physics and is a current member of several professional societies nationally and internationally. Dr. Tolmachev is the Guest Editor for Health Physics journal's special issue dedicated to the USTUR's 50 y of operation and research.
Dr. Tolmachev has over 20 y of experience in the development of analytical methods, and in actinide analyses of environmental and biological samples. He is an expert in state-of-the-art analytical instrumentation, including various types of inductively coupled plasma mass spectrometers (ICP-MS), high performance liquid chromatography, and alpha-spectrometry systems. Dr. Tolmachev earned his Diploma of nuclear technology engineer (MS equivalent) at the Mendeleyev University of Chemical Technology of Russia (Moscow) in 1993, majoring in radiation and radiochemistry. His Master's Thesis project was completed at the Joint Institute for Nuclear Researches (JINR) in Dubna, Russia. After graduation, he joined the Radioanalytical Research Group at JINR. In 1997, he was awarded a scholarship by the Ministry of Education, Culture and Sport of Japan for research and doctoral study at Kyushu University (Fukuoka) in the field of Environmental Radiochemistry/Radioecology. His research focused on 210Po, 36Cl, and 3H determination and behavior in the environment. He developed a radioanalytical protocol for 36Cl determination by projectile x-ray accelerator mass spectrometry. Dr. Tolmachev was awarded the degree of Doctor of Science (PhD equivalent) in 2001. He continued his scientific career with two postdoctoral fellowships in Japan: at the Japan Atomic Energy Research Institute (Tokai-mura), Department of Health Physics; and at the National Institute of Radiological Sciences (Chiba), Research Center for Radiation Safety. During this period, his research focused on applying ICP-MS techniques for uranium (234U, 235U, 238U) and 232Th isotopic determination in human body fluids, actinide biokinetics, and internal dose assessment. He established a rapid automated flow-injection ICP-MS method for uranium isotopic determination for the purpose of internal dose assessment. Dr. Tolmachev conducted a milestone study of the concentration and daily excretion of uranium in urine of Japanese (to better define the exposure of the Japanese population to natural uranium). His Japanese research also included method development to apply sector field ICP-MS to measure 226Ra in environmental samples.
Dr. Tolmachev is an internationally recognized scientist. In addition to directing the USTUR, he is an Adjunct Professor at the Department of Chemistry of Laval University (Canada); a Visiting Professor at Kyushu University, Radioisotope Center (Japan); and Technical Advisor at Kyushu Environmental Evaluation Association (Japan). While working at WSU, he has established active scientific collaborations with the European Radiation Dosimetry Group WG-7 on Internal Dosimetry, Karlsruhe Institute of Technology (Germany), Public Health England (United Kingdom), and Radiation Protection Bureau at Health Canada, as well as with the leading U.S. laboratories such as Pacific Northwest National Laboratory and Radiation Emergency Assistance Center/Training Site.
MICHAEL M. WEIL
is a professor in the Department of Environmental and Radiological Health Sciences at Colorado State University (CSU). His research, which takes advantage of murine models of radiation carcinogenesis and leukemogenesis, is focused on understanding how radiation exposure can lead to cancer and why some individuals may be more susceptible than others. At CSU, Dr. Weil teaches a graduate level course in cancer genetics and lectures in courses on cancer biology, environmental carcinogenesis, principles of radiation biology, and the pathobiology of laboratory animals.
Dr. Weil earned his PhD in Microbiology from the University of Texas at Austin and was trained in cancer genetics and radiation biology in the Department of Biochemistry and Molecular Biology Biochemistry and the Department of Experimental Radiotherapy at the University of Texas M.D. Anderson Cancer Center. Dr. Weil is a Radiation Research Society council member and has served on National Institutes of Health, U.S. Department of Defense, and National Aeronautics and Space Administration grant review panels.
Jeffrey J. Whicker
Jeffrey Whicker has worked at Los Alamos National Laboratory for over 25 y. He received a PhD in Environmental and Radiological Health Science from Colorado State University and is certified by the American Board of Health Physics. He is an author or co-author on over 125 scientific publications, invited talks, book chapters, and presentations mostly on indoor and outdoor radiological air quality and measurement that span issues ranging from worker protection, homeland security, public risk assessment, and environmental quality. His body of work has been cited in peer-reviewed journals over 500 times. Dr. Whicker served on the Editorial Board for the journal Radiation Protection Dosimetry and as President of the Environmental/Radon Section of the Health Physics Society.
ROBERT C. WHITCOMB, JR.
joined the Centers for Disease Control and Prevention (CDC) in June 1993. He is currently the Lead Physical Scientist with the Radiation Studies Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health. In this position he serves as Radiation Subject Matter Expert and CDC Spokesperson for technical and public health issues related to environmental radiation and nuclear/radiological emergency response. Previously, Dr. Whitcomb worked with the Illinois Department of Nuclear Safety. His primary area of expertise is the assessment of radionuclides released to the environment and the impact on public health. He has authored or coauthored numerous journal articles and has lectured nationally and internationally about the public health response in nuclear/radiological emergencies.
Dr. Whitcomb is a member of NCRP and the Health Physics Society. He is certified in comprehensive practice by the American Board of Health Physics, and served on the Board of Directors of the Health Physics Society (2004 to 2007). Dr. Whitcomb holds a BS in Biology from Florida Southern College, an MS and a PhD in Environmental Engineering Sciences from the University of Florida.
Jessica S. Wieder
Jessica Wieder is an expert in radiation risk communication. As a member of NCRP’s Program Area on Radiation Education, Risk Communication and Outreach, Ms. Wieder helped write NCRP Report No. 179, Guidance for Emergency Response Dosimetry, and plan the outreach for high profile publications such as NCRP Report No. 180 on Management of Exposure to Ionizing Radiation: Radiation Protection Guidance for the United States (2018), and Commentary No. 27 on the Implications of Recent Epidemiologic Studies for the Linear-Nonthreshold Model and Radiation Protection. Also working through NCRP, Ms. Wieder and Brooke Buddemeier became TED educators on how to survive nuclear fallout.
Ms. Wieder is the Director of the Center for Radiation Information and Outreach at the U.S. Environmental Protection Agency (EPA). She served at EPA’s senior radiation public information officer during the 2011 Fukushima Daiichi nuclear accident, facilitated international panels on emergency response public communication, and was part of the contingency planning team for the 2011 launch of the Mars Science Laboratory. In 2013, she was awarded EPA's Exemplary Customer Service Award for her leadership in enabling all levels of government to provide quick, effective communications to the American people in response to large-scale radiological emergencies.
In 2010, Ms. Wieder was detailed to Federal Emergency Management Agency's Chemical, Biological, Radiological, Nuclear and Explosives Branch, where she created the intergovernmental Nuclear/Radiological Communications Working Group. With her guidance, this group developed the nuclear detonation messaging document Improvised Nuclear Device Response and Recovery: Communicating in the Immediate Aftermath.
JACQUELINE P. WILLIAMS
completed her undergraduate degrees at the University of Nottingham, followed by her post-doctoral training in radiation biology at St. Bartholomew's Hospital, University of London, U.K. Shortly after completing her studies, she joined the faculty at the University of Rochester, New York, in the department of Radiation Oncology, and recently in the department of Environmental Medicine. Since that time, Dr. Williams has accrued more than 25 y of experience in radiation biology and related fields and has been involved in a wide range of research areas, including clinically-related oncologic studies and clinical trials, tumor blood flow studies, long-term carcinogenic studies, and pharmacological and toxicological projects.
Her current research interests involve identifying mechanisms that underlie the initiation and progression of radiation-induced late normal tissue effects as a consequence of high-dose clinical treatment/accidental exposures or the lower doses associated with either space travel or mass exposures with the goal of developing protection or mitigation strategies. Dr. Williams has served as the President of the Radiation Research Society, the Research Chair on the Board of the American Society for Radiation Oncology, and has been elected to, and is currently serving as, Council Member to the International Association for Radiation Research.
John P. Winston
is a Radiation Health Physicist for the Pennsylvania Bureau of Radiation Protection. He has drafted regulations on x-ray producing machines used in the Commonwealth and coauthored Pennsylvania studies on fluoroscopy, computed tomography, and dental panoramic x rays. He chaired several Conference of Radiation Control Program Directors (CRCPD) committees: H-7 (Quality Assurance in Diagnostic X Ray), H-22 (Reducing Risk from Fluoroscopy Procedures), and SR-F (Suggested Regulations for Diagnostic and Interventional X Ray). He is currently a member of committee H-46 on IEC Standards. He previously served as a member of CRCPD's H-39 (Computed Tomography Brain Perfusion) and H-38 (Medical Events) committees.
Mr. Winston served on CRCPD's Board of Directors for 7 y, including terms as the Chairperson and the Treasurer. While on the Board he was appointed as CRCPD's first Liaison to the American Society for Radiation Oncology and also served as their Liaison to the American Association of Physicists in Medicine. In recognition for his dedicated work, Mr. Winston was presented the James W. Miller Award and the Gerald S. Parker Award of Merit.
He was a member of the Interagency Steering Committee on Radiation Standards Working Group on Medical Radiation charged with writing the Federal Guidance Report No. 14: Radiation Protection Guidance for Diagnostic and Interventional X-Ray Procedures, and the NCRP Scientific Committee 4-6.
Mr. Winston is a member of NCRP and serves on the Program Area Committee on Radiation Protection in Medicine.
GAYLE E. WOLOSCHAK
is a Professor of Radiation Oncology and Radiology at Northwestern University Feinberg School of Medicine in Chicago. She and her group have been involved in studies of molecular consequences of radiation exposure, late tissue effects associated with radiation, and the use of radiation-inducible nanomaterials for cancer imaging and therapy. Dr. Woloschak also teaches radiation biology to radiation oncology and radiology residents, cardiology trainees, and graduate students and manages the Advanced Grant Writing Workshop for the Radiological Society of North America (RSNA). She earned her PhD in medical sciences from the University of Toledo (Ohio) and did post-doctoral studies in molecular biology at the Mayo Clinic. She has served on review panels for various federal agencies including the National Institutes of Health, the National Aeronautics and Space Administration, the U.S. Department of Energy, RSNA, the U.S. Army Medical Research and Materiel Command, and others. She is currently an associated editor for Radiation Research, the International Journal of Radiation Biology, PLOS One, and Nanomedicine. She is Vice President of NCRP Program Area Committee 1, has served on organizational committees for several NCRP meetings, and has been involved in committees for several NCRP reports. She also served as Vice-President of the Radiation Research Society.
X. GEORGE XU
is a Professor of Nuclear Engineering at Rensselaer Polytechnic Institute (RPI) in Troy, New York. He received a PhD in nuclear engineering from Texas A&M University in 1994 before joining RPI. Since 2011, he has been the head of RPI's Nuclear Engineering Program involving 20 faculty/staff members, 160 undergraduate/graduate students, and two major nuclear research laboratories: the Gaerttner Linear Accelerator and the Walthousen Reactor Critical Facility. In addition to the faculty appointment at RPI, Dr. Xu also served from 1995 to 2000 as the Director of Office of Radiation and Nuclear Safety/Institute Radiation Safety Officer, responsible for the development and management of a comprehensive radiation and nuclear safety program at RPI, including operational radiation safety, nuclear instrumentation, compliance with federal and state regulations, environmental health, and nuclear security. In his research, Dr. Xu is internationally known for pioneering work on radiation dosimetry using computational phantoms (stylized, voxel, and BREP phantoms) and Monte-Carlo simulations. Since 1995, Dr. Xu has attracted and managed a total of $15M worth of external funding from the National Science Foundation (NSF), the U.S. Department of Energy, the National Institutes of Health, and the National Institute of Standards and Technology, as well as private-sector industry as the principal investigator.
His research projects cover broad topics in nuclear contamination characterization, radiation protection of workers in nuclear power plants, modeling of complex reactor and accelerator systems, medical imaging and radiotherapy involving x rays, electrons and protons. In 2012, he led the projects to develop a computed tomography dose reporting software called VirtualDose and a new Monte-Carlo radiation transport code called Archer that utilizes hardware accelerators such as NVIDIA's GPU and INTEL's Xeon Phi. Mostly working with his former graduate students (15 PhD and 10 MS), Dr. Xu has authored/coauthored 140 peer-reviewed papers and chapters, 250 conference abstracts, 90 invited seminars/presentations, and several software packages. His 2000 paper on the VIP-Man phantom was one of the most cited paper in the field of computational phantoms (http://scholar.google.com/citations?user=dMkZjf8AAAAJ&hl=en). He cofounded the Consortium of Computational Human Phantoms (www.virtualphantoms.org) and coedited the book entitled "Handbook of Anatomical Models for Radiation Dosimetry" involving 60 authors from 13 countries. He serves on the editorial board of numerous journals including Medical Physics, Physics In Medicine and Biology, and Radiation Protection Dosimetry. He organized the International Workshop on Computational Phantoms for Radiation Protection, Imaging and Radiotherapy, in Beijing in 2011 and then in Zurich in 2013.
Dr. Xu is a member of American Nuclear Society (ANS) (life member and fellow), American Association of Physicists in Medicine (fellow), Health Physics Society (fellow), and Council on Ionizing Radiation Measurements and Standards (past president). He was elected to serve as a Council member of NCRP in 2008, and a member of U.S. Environmental Protection Agency's Science Advisory Board (SAB) Radiation Advisory Committee in 2012. Dr. Xu received numerous awards including the NSF/CAREER Award, Rensselaer Research Excellence Award, ANS Best-Paper Award, Journal of Physics in Medicine and Biology Best-Paper Award, and ANS/RPSD Professional Excellence Award.
R. CRAIG YODER
directed Landauer's technical activities relating to radiation dosimetry, particularly for applications in radiation protection from 1983 through his retirement in 2015. Additionally, he oversaw subsidiary and partner businesses located in Australia, Brazil, China, France, Mexico, Japan, Sweden and Turkey.
An internationally known expert in radiation monitoring, Dr. Yoder led Landauer's transition from film and thermoluminescent dosimetry technology to optically stimulated luminescence, an assignment that required strategic planning and direction in areas spanning scientific research, product development, manufacturing, laboratory operations and marketing. From 1993 to 2001, he was Vice President of Operations and managed Landauer's manufacturing and analytical laboratory activities in addition to overseeing research and development programs.
Dr. Yoder is a member of NCRP and former President of the Council on Ionizing Radiation Measurements and Standards. He has served on several national and international committees to develop dosimetry standards. He was a member of a National Research Council committee that examined the accuracy of film badge measurements made during atmospheric nuclear weapons testing.
Dr. Yoder earned his MS and PhD degrees in Bionucleonics at Purdue University and received a BS in Pre-Medicine from Davidson College. He also completed the Executive Program at Stanford University. He is Certified in Comprehensive Health Physics by the American Board of Health Physics.
Lydia B. Zablotska
is a Professor in the Department of Epidemiology and Biostatistics in the School of Medicine at the University of California, San Francisco (UCSF), where she serves as the Leader of the Occupational and Environmental Epidemiology Area of Concentration. Dr. Zablotska is a physician and epidemiologist with extensive training and publications in radiation epidemiology, biostatistics, and risk modeling. Her research activities have focused primarily on the examination of risks of radiation exposures in various occupational and environmental settings. Dr. Zablotska's work has clarified the understanding of the effects of occupational radiation exposures on health risks of nuclear power industry workers and workers of the uranium fuel production cycle in various occupational cohorts from the United States and Canada. As a Principal Investigator of the National Cancer Institute-funded Chernobyl studies, she published a number of important publications with the tri-national investigative team which showed that exposures to ingested and inhaled radioactive iodines during childhood lead to increased risks of thyroid cancer similar to risks from external radiation. Study findings redefined the emergency protocols for populations working or living around nuclear power plants and opened a new area of inquiry by showing that exposures to radioiodines increase not only the risks of thyroid cancer, but also of benign thyroid tumors such as follicular adenomas. Recently, the research conducted by Dr. Zablotska's research group showed that the cleanup workers of the Chernobyl nuclear accident are at increased risk of incident chronic lymphocytic leukemia and reported possible links with somatic point mutations related to telomere length maintenance. Dr. Zablotska serves as a Director of Epidemiology, Biostatistics and Population Health education in the medical school curriculum at UCSF and has received multiple institutional and national teaching and mentoring awards. She is the founder of the Early Stage Radiation Investigators Workshop conducted in conjunction with biennial meetings of the Conference on Radiation and Health.>/p>
Pat B. Zanzonico
received a BS in Physics from Cooper Union in 1977 and a PhD in Biophysics from the Cornell University Graduate School of Medical Sciences in 1982. He served on the faculty of the Department of Radiology (Nuclear Medicine) of the New York Hospital-Cornell Medical Center and is currently a Member and Attending Physicist at Memorial Sloan Kettering Cancer Center, Co-Head of the Center's Small-Animal Imaging Laboratories, and Chairman of its Committee on Radiation. He also serves on the Special Contributing Faculty of the Gerstner Sloan-Kettering Graduate School and is an Adjunct Professor of Applied Physics and Mathematics at Columbia University. Dr. Zanzonico is Associate Editor of the British Journal of Radiology and the European Journal of Nuclear Medicine and a member of the Editorial Boards of the Journal of Nuclear Medicine and Medical Physics. He is also a member of the Medical Internal Radionuclide Dosimetry Committee of the Society of Nuclear Medicine and Molecular Imaging and Vice-Chairman of the U.S. Nuclear Regulatory Commission’s Advisory Committee on Medical Uses of Isotopes, and a past Consultant to the International Atomic Energy Agency. Dr. Zanzonico has over 120 peer-reviewed publications and over 75 invited presentations. He is actively involved in biomedical research on radionuclide-based methods for detecting and localizing tumor hypoxia, immune effector-cell trafficking, patient-specific dosimetry for radionuclide therapies, and small-animal and molecular imaging.
Cary J. Zeitlin
is a Senior Research Scientist with Leidos Innovations Corporation, working for the National Aeronautics and Space Administration (NASA) Johnson Space Center Space Radiation Analysis Group to assess exposures and risks to astronauts in current and future mission scenarios. He began his career in particle physics in the early 1980s, scanning nuclear emulsion that had been exposed to a beam of high-energy iron ions at the Lawrence Berkeley Laboratory (LBL) Bevalac. As this is one of the most tedious jobs imaginable, greener pastures soon beckoned, leading him to join the TPC/Two-Gamma Collaboration at the Stanford Linear Accelerator Center. After receiving his PhD in experimental high-energy physics and spending another 3 y at the Stanford Linear Accelerator Center as a postdoc studying the decays of the Z boson, Dr. Zeitlin returned to LBL and to nuclear physics in 1991 to work on a long-term project measuring the fragmentation cross sections most pertinent to NASA’s space radiation transport codes. This experience led to his taking over as Principal Investigator of the Martian Radiation Environment Experiment (MARIE) aboard the Mars Odyssey orbiter following the untimely passing of Dr. Gautam Badhwar. This led subsequently to his role as Co-Investigator with the Radiation Assessment Detector (RAD) project starting in 2008, as the instrument was being prepared for integration into the Curiosity Rover. After the successful transit and spectacular landing of Curiosity on Mars in 2012, RAD has been operating almost without interruption on the surface, sending back the first detailed radiation environment measurements from another planet. A second RAD was built for the International Space Station and began flight operations in early 2016. Dr. Zeitlin has received two Outstanding Performance awards from LBL and has received three awards from NASA for his work on the MARIE, RAD, and CRaTER projects. He was elected to the NCRP in 2014.
(as of March 24, 2020)